<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="http://jekyllrb.com" version="3.4.1">Jekyll</generator><link href="https://www.wardle.org/feed.xml" rel="self" type="application/atom+xml" /><link href="https://www.wardle.org/" rel="alternate" type="text/html" /><updated>2017-05-31T15:59:01+01:00</updated><id>https://www.wardle.org/</id><title type="html">Dr. Mark Wardle</title><subtitle>Consultant Neurologist, clinical informatics, entrepreneur and software developer.
</subtitle><entry><title type="html">PatientCare EPR: care plans</title><link href="https://www.wardle.org/clinical-informatics/2017/05/30/patientcare-care-plans.html" rel="alternate" type="text/html" title="PatientCare EPR: care plans" /><published>2017-05-30T22:56:00+01:00</published><updated>2017-05-30T22:56:00+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/05/30/patientcare-care-plans</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/05/30/patientcare-care-plans.html">&lt;p&gt;In a &lt;a href=&quot;/clinical-informatics/2017/05/27/patientcare-epr.html&quot;&gt;recent blog post&lt;/a&gt;, I gave a whirlwind tour of some of the functionality within the PatientCare EPR. There is a lot I haven’t really mentioned and so, I thought I’d add some details over a few other blog posts.&lt;/p&gt;

&lt;p&gt;A care plan is a document that sets out a patient’s future care and support. Patients should be fully involved in the preparation of such a care plan and ideally this plan should contain:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;what are the intended &lt;em&gt;outcomes&lt;/em&gt; for a patient, including wishes and preferences.&lt;/li&gt;
  &lt;li&gt;an assessment of the &lt;em&gt;needs&lt;/em&gt; of a patient in order to achieve those outcomes&lt;/li&gt;
  &lt;li&gt;how those needs are to be &lt;em&gt;met by the agencies&lt;/em&gt; involved in supporting that patient&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;As such, a care plan should be individualised and specific for a single patient and will need to include plans for the care in a range of care domains, such as medical, nursing and social.&lt;/p&gt;

&lt;p&gt;However, there are types of care plans aimed at different scenarios, such as an emergency care plan to document a plan of care should there be an emergency deterioration in a patient’s health. Such a plan would focus on ensuring that emergency unit staff know what to do and this kind of plan can be particularly helpful for patients with long-term health conditions.&lt;/p&gt;

&lt;h1 id=&quot;care-plans-within-the-patientcare-epr&quot;&gt;Care plans within the PatientCare EPR.&lt;/h1&gt;

&lt;p&gt;I have built an emergency care plan registry within the PatientCare EPR.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/schematic-care-plan.png&quot; alt=&quot;Schematic Care Plan&quot; /&gt;&lt;/p&gt;

&lt;p&gt;The idea being that we could configure our emergency unit system to check for the presence of an emergency care plan via a REST API and ensure that caregivers have access to that plan in safely and securely.&lt;/p&gt;

&lt;h4 id=&quot;building-individualised-plans&quot;&gt;Building individualised plans&lt;/h4&gt;

&lt;p&gt;Modelling care plans requires an understanding of the processes and workflow that create and maintain those plans. As such, it is not sufficient to simply model the data relating to a care plan.&lt;/p&gt;

&lt;p&gt;For instance, care plans are typically collaborative documents in which multiple authors work to create a unified document. In addition, the users involved need to know the care plans for which they are responsible. Most importantly, how many of us have seen guidelines, protocols and care plans with an expiry date many months or years in the past? As such, it is vital that there are processes in place to identify out-of-date care plans and ensure that they are kept up to date.&lt;/p&gt;

&lt;p&gt;Historically, healthcare professionals have relied on patients turning up in clinic in order to drive their healthcare. This is an outdated and inefficient way of running a health service. If we truly want a responsive service, we need to ensure that information technology is used to its fullest in order to enable care.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/first-draft.png&quot; alt=&quot;First Draft&quot; /&gt;&lt;/p&gt;

&lt;p&gt;In this first screenshot, we generate a care plan. It is automatically populated by the contents of the emergency care guidance from any clinical services for which the patient is registered. I can add a number of users so for example, if I have a paediatric patient with epilepsy and nutritional problems, one section may the responsibility of a paediatric neurologist and the other a gastroenterologist.&lt;/p&gt;

&lt;p&gt;Each user can edit or add new sections and order those sections:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/seizures.png&quot; alt=&quot;Seizures&quot; /&gt;&lt;/p&gt;

&lt;p&gt;which then populate the care plan document:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/second-draft.png&quot; alt=&quot;Second Draft&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Users can choose the review date and the expiry date and users receive notifications when a care plan needs to be reviewed or signed.&lt;/p&gt;

&lt;p&gt;Once a user signs off the document, the content is locked until either all users have signed it off, or someone unlocks the document. Only after all users sign off the document is it finally &lt;a href=&quot;/images/care-plans/care-plan.pdf&quot;&gt;published to the repository&lt;/a&gt;:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/final-output.png&quot; alt=&quot;Final Output&quot; /&gt;&lt;/p&gt;

&lt;h4 id=&quot;but-how-can-we-do-this-for-thousands-of-patients&quot;&gt;But how can we do this for thousands of patients?&lt;/h4&gt;

&lt;p&gt;Care plans are particularly useful for those patients with complex needs and multiple co-morbidities. For such patients, it is easy to see how investing time and resource in preparing and maintaining emergency care plans can improve patient care in the event of an emergency. But how can we do this for all of the patients under our care?&lt;/p&gt;

&lt;p&gt;Within the PatientCare EPR, all patients are registered to clinical services and projects by virtue of an episode of care. This episode may be lifelong for a long-term health condition, or short for an acute clinical service. As health professionals are registered with different roles to different services, this permits a finely grained security model in which only those staff involved in the direct care of that patient has access to the record.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/patient-project-membership.png&quot; alt=&quot;Patient Project Membership&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Furthermore, this model provides a way of building dynamic care plans for all of the patients under our care. As such, the PatientCare EPR can automatically generate a default care plan individualised to that patient by virtue of that patient’s membership of different clinical teams.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/editing-service-care-plan.png&quot; alt=&quot;Editing Service Care Plan&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Here I edit the configuration for a local Parkinson’s disease service. This will be used to automatically generate a care plan for the patients registered to that service.&lt;/p&gt;

&lt;p&gt;I have built a REST-based API that looks for manually-created emergency care plan but, if that doesn’t exist and the clinical services are configured to have “automatic care plan generation” turned on, the system will dynamically generate a document for the use of emergency services.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/care-plans/pd-drug-timings.png&quot; alt=&quot;Pd Drug Timings&quot; /&gt;&lt;/p&gt;

&lt;p&gt;In this example, I have linked to the &lt;a href=&quot;https://www.parkinsons.org.uk/sites/default/files/publications/download/english/pk0135_emergencymanagement.pdf&quot;&gt;Parkinson’s UK emergency care guidelines&lt;/a&gt; and emphasised that patients with Parkinson’s disease need their medications administered on time.&lt;/p&gt;</content><author><name></name></author><summary type="html">In a recent blog post, I gave a whirlwind tour of some of the functionality within the PatientCare EPR. There is a lot I haven’t really mentioned and so, I thought I’d add some details over a few other blog posts.</summary></entry><entry><title type="html">PatientCare EPR: design principles</title><link href="https://www.wardle.org/clinical-informatics/2017/05/27/patientcare-epr.html" rel="alternate" type="text/html" title="PatientCare EPR: design principles" /><published>2017-05-27T22:02:00+01:00</published><updated>2017-05-27T22:02:00+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/05/27/patientcare-epr</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/05/27/patientcare-epr.html">&lt;p&gt;The PatientCare electronic patient record system is a web-based application accessible across NHS Wales that records diagnostic, treatment and interventional treatment. It is underpinned by SNOMED-CT, a modern sophisticated and comprehensive terminology system that acts as the ‘lingua franca’ to provide algorithmic understanding and dynamic functionality. While the main functionality is available via a web-based portal, users can also interact with the software using bespoke iPhone and iPad applications.&lt;/p&gt;

&lt;p&gt;It has resulted in clinical information becoming available immediately at the point-of-care. The neuro-inflammatory team used to use paper notes with filing cabinets full of brown folders; now they are paper-free. It records not only a prospective longitudinal narrative, acting as a customer-relationship-manager, but records both clinician-derived and patient reported outcome measures. In addition, while fundamentally it is a system to support the direct care of patients, it additionally supports the dynamic real-time aggregation of data for service management.&lt;/p&gt;

&lt;p&gt;Finally, it supports the registration and management of clinical research projects, managing consent and access privileges using a finely-grained security model. This allows the recording of deep clinical phenotypes combined with a record of biological samples such as plasma, serum, DNA and cerebrospinal fluid. As such, we not only know that the serum was taken from a patient with, for example, epilepsy, but we also know how that biological sample was taken on the same day as a generalised tonic-clonic seizure.&lt;/p&gt;

&lt;p&gt;I have been building this system since 2009. This blog post is an overview of the functionality available and the underlying design principles.&lt;/p&gt;

&lt;hr /&gt;

&lt;h1 id=&quot;1-start-with-a-problem&quot;&gt;1. Start with a problem&lt;/h1&gt;

&lt;p&gt;When designing clinical information systems, the priority must be to solve a problem. It is therefore vital to understand and frame the problems, work on making those problems as generic as possible without losing functionality, and plan for a phased iterative development in which early designs are built with future needs in mind.&lt;/p&gt;

&lt;p&gt;One important problem we face in hospital medicine is an understanding of our patients and their outcomes. You might be surprised to know that my own organisation knows how many patients attend outpatient clinics, but they have little idea why they were seen, what had been done or how they have fared. Indeed, there are now ongoing projects to record patient outcome measures from patients when their appointment letters are sent to them, but how can anyone interpret those data without an understanding of the problems those patients face?&lt;/p&gt;

&lt;p&gt;Example problems might include:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;How many patients with [Parkinson’s disease] in Wales?&lt;/li&gt;
  &lt;li&gt;How many patients with [epilepsy] refractory to two drugs?&lt;/li&gt;
  &lt;li&gt;Who might be eligible for this new [treatment / research project / intervention]?&lt;/li&gt;
  &lt;li&gt;Who of my patients is taking [methotrexate] and need monitoring?&lt;/li&gt;
  &lt;li&gt;Tell me when any of my patients with [epilepsy] attends A&amp;amp;E.&lt;/li&gt;
  &lt;li&gt;Tell me when my patient loses 5% of their body weight compared to weight at diagnosis.&lt;/li&gt;
  &lt;li&gt;How do patients fare after having a [ventriculo-peritoneal shunt] procedure?&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;This information is actually available, but it will generally be recorded in individual patient notes. The only way of knowing how many patients we see with Parkinson’s disease for example would be to task someone to go through the paper records or outpatient letters and manually count them up. Therefore, while this information is available, it isn’t accessible at the point of care or in any format that permits dynamic, real-time monitoring and understand of our clinical services.&lt;/p&gt;

&lt;p&gt;The PatientCare EPR supports solving all of these problems, but does so by creating a generic solution applicable to a wide-range of clinical problems.&lt;/p&gt;

&lt;hr /&gt;
&lt;h1 id=&quot;2-move-to-a-model&quot;&gt;2. Move to a model&lt;/h1&gt;

&lt;p&gt;Once you know the problems that need to be solved, it is tempting to start thinking about how your clinical information system is going to look and behave. However,  you should instead consider your high-level functional requirements and the model of the world that will support those requirements. I write about clinical modelling in my &lt;a href=&quot;/clinical-informatics/2017/02/03/domain-driven-design.html&quot;&gt;Domain-driven clinical design document&lt;/a&gt; but essentially a model is an abstraction of reality. Clinical modelling requires both time and collaboration, between experts in the problem domain and experts with the required technical skills.&lt;/p&gt;

&lt;p&gt;I suggest dividing clinical modelling into three related steps:&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;Modelling data within a medical record&lt;/li&gt;
  &lt;li&gt;Modelling processes and workflow relating to a medical record&lt;/li&gt;
  &lt;li&gt;Implementation of a clinical model into a workable and practical solution.&lt;/li&gt;
&lt;/ol&gt;

&lt;p&gt;These three steps should be considered separately but are dependent on one another and inherently depend on the functional requirements. In designing clinical information systems, a data model may change infrequently or a design may even be correct in perpetuity; a systolic blood pressure recorded using a cuff on the right arm of an individual will always be a systolic blood pressure recorded using a cuff on the right arm of an individual. However, a model of the processes of care will likely change more frequently as a result of changes in working practices and service design, and an implementation may change even more frequently as a result of new technologies and devices.
As each step is dependent on each other, modelling must be an iterative work with feedback loops between all steps rather than performed in sequence by different members of the team. An implementation cannot be designed without consideration of the data structures and processes that leverage the data within those structures and a model cannot be designed unless it is practical and efficient to perform an implementation. It also follows that clinical modelling must be performed by a team of individuals with a range of skills including those with important domain knowledge such as health professionals as well as those responsible for the design and implementation of the resulting software such as technical architects and software developers.&lt;/p&gt;

&lt;p&gt;However, as part of this iteration, I don’t suggest trying to do detailed planning. Historically, the health service has developed software by providing detailed requirements and planning systems in detail with the stages of development build using a Gantt chart. Advocates of such an approach suggest that this lowers risk and maps the process of development from initiation to final deployment. The use of a Gantt chart typically creates a project plan that looks like a waterfall, and so this is typically termed the &lt;a href=&quot;https://en.wikipedia.org/wiki/Waterfall_model&quot;&gt;“waterfall model”&lt;/a&gt;. Instead, I would advocate a more agile and iterative approach in which the three related steps of clinical modelling listed above are used as part of a series experiments in order to test those models and our assumptions and ensure that what will be created will actually be valuable.&lt;/p&gt;

&lt;hr /&gt;
&lt;h1 id=&quot;3-example-requirements&quot;&gt;3 Example requirements&lt;/h1&gt;

&lt;p&gt;It might be useful to consider some examples of functional requirements and the data required to solve those problems.&lt;/p&gt;

&lt;h4 id=&quot;support-the-derivation-of-incidence-and-prevalence-of-a-range-of-rare-diseases&quot;&gt;Support the derivation of incidence and prevalence of a range of rare diseases&lt;/h4&gt;

&lt;p&gt;Given this task, we might consider first how to calculate incidence and prevalence and decide that we need:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;a list of patients, including dates of birth and death&lt;/li&gt;
  &lt;li&gt;their current and previous addresses and the dates on which they moved.&lt;/li&gt;
  &lt;li&gt;a method to map addresses to wider geographic areas, such as health authority boundaries&lt;/li&gt;
  &lt;li&gt;a record of diagnoses and the dates of both diagnosis and onset.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;With these data, it is conceivable that we can generate incidence and prevalence data for any disease at any time point.&lt;/p&gt;

&lt;p&gt;The PatientCare EPR has underpinned our local multiple sclerosis epidemiology projects for many years. At the touch of a button, I can generate incident and prevalence data. Here is an example:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/patientcare-epidem-data.png&quot; alt=&quot;Patientcare Epidem Data&quot; /&gt;&lt;/p&gt;

&lt;h4 id=&quot;send-an-alert-when-one-of-my-patients-with-mnd-loses-5-of-their-body-weight&quot;&gt;Send an alert when one of my patients with MND loses 5% of their body weight&lt;/h4&gt;

&lt;ul&gt;
  &lt;li&gt;a list of patients&lt;/li&gt;
  &lt;li&gt;a record of diagnoses and the dates of both diagnosis and onset.&lt;/li&gt;
  &lt;li&gt;a way of identifying motor neurone disease whether the patient is recorded as having “MND” or a subtype such as “progressive bulbar palsy”.&lt;/li&gt;
  &lt;li&gt;a longitudinal record of body weight&lt;/li&gt;
  &lt;li&gt;a method to track clinical users and handle notifications&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;The PatientCare EPR does this dynamically and presents the information in a dashboard, but also sends me an alert when it recognises a patient has lost weight:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/mnd-dashboard.png&quot; alt=&quot;Mnd Dashboard&quot; /&gt;&lt;/p&gt;

&lt;h4 id=&quot;show-me-how-this-patient-with-multiple-sclerosis-is-doing-compared-to-their-peers&quot;&gt;Show me how this patient with multiple sclerosis is doing compared to their peers&lt;/h4&gt;

&lt;ul&gt;
  &lt;li&gt;a list of patients&lt;/li&gt;
  &lt;li&gt;a record of diagnosis and the dates of both diagnosis and onset.&lt;/li&gt;
  &lt;li&gt;a longitudinal record of disease outcome, perhaps generic, perhaps disease-specific, perhaps both.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;In this image, progression of disability for the whole cohort is shown (dotted lines indicated median and centiles) with an individual’s progress overlaid. In addition, my colleagues can dynamically change the inclusion and exclusion criteria that defines the cohort. For example, a man presenting with multiple sclerosis at the age of 35 can be shown against other men presenting between age 30 and 40 to easily see how the individual is doing compared to their peers.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/edss-graph.jpg&quot; alt=&quot;Edss Graph&quot; /&gt;&lt;/p&gt;

&lt;h4 id=&quot;record-patient-encounters-such-as-telephone-calls-and-allow-team-working&quot;&gt;Record patient encounters such as telephone calls and allow team-working&lt;/h4&gt;

&lt;ul&gt;
  &lt;li&gt;a list of patients&lt;/li&gt;
  &lt;li&gt;a list of teams&lt;/li&gt;
  &lt;li&gt;a list of users&lt;/li&gt;
  &lt;li&gt;linkage between patients, teams and users in order to support team working and understand who is involved in the care of whom&lt;/li&gt;
  &lt;li&gt;security access control to use that linkage to decide on patient record access&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;The PatientCare EPR now records thousands of messages every month. Users can choose to receive emails when a message is sent, with the software sending messages with patient identifiable information if they have an NHS email account but only a notification if they have registered with a non-NHS account such as their university email.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/patientcare-messages.png&quot; alt=&quot;Patientcare Messages&quot; /&gt;&lt;/p&gt;

&lt;hr /&gt;
&lt;h1 id=&quot;4-solving-our-problems&quot;&gt;4. Solving our problems&lt;/h1&gt;

&lt;p&gt;It is clear that many of these functional requirements are generic and widely-applicable, irrespective of disease, treatment or intervention. Indeed, why limit comparing a single patient with their peers based only on diagnosis? Instead, consider how one might design systems that allow such comparisons based on other characteristics, such as a particular type of procedure, an admission under a particular specialty or an outpatient appointment.&lt;/p&gt;

&lt;p&gt;A focus on the user interface means that when one broadens the scope of a problem, it is possible to create complexity and confusion. However, broadening the scope of a problem at a domain-model level often simplifies our work, by providing insight into how one requirement is in fact closely related to another. Defining the appropriate scope of a problem is therefore critical to create usable, workable and valuable clinical information systems.&lt;/p&gt;

&lt;p&gt;Essentially we need to build an information model representing the data and the relationships between those items of data. Such modelling requires an understanding of the “nouns” in healthcare as well as the processes (the “verbs”) that represent actions on those nouns.&lt;/p&gt;

&lt;p&gt;However, no solution exists in isolation. Instead, any clinical information system must interoperate with other systems within a wider health enterprise, either within a single organisation or, increasingly, across organisations. There is now increasing momentum towards open architectures in which healthcare data can be represented in a standardised fashion and I have written about openEHR, HL7 FHIR and SNOMED-CT in my &lt;a href=&quot;/cis-design/2017/05/02/data-standards.html&quot;&gt;data standards blog post&lt;/a&gt;.&lt;/p&gt;

&lt;h4 id=&quot;snomed-ct&quot;&gt;SNOMED-CT&lt;/h4&gt;

&lt;p&gt;I have previously also discussed SNOMED-CT in detail (in discussing the &lt;a href=&quot;/clinical-informatics/2017/04/28/importance-of-cohorts.html&quot;&gt;importance of cohorts&lt;/a&gt;, in releasing an &lt;a href=&quot;/clinical-informatics/2017/04/29/rsterminology-part2.html&quot;&gt;open-source SNOMED-CT terminology server&lt;/a&gt; and in &lt;a href=&quot;/clinical-informatics/2017/05/20/using-snomed-ct.html&quot;&gt;using SNOMED CT to understand meaning&lt;/a&gt;).&lt;/p&gt;

&lt;p&gt;Essentially, SNOMED-CT provides two key features that underpin solving many of our clinical problems.&lt;/p&gt;

&lt;p&gt;Firstly, it provides a terminology, a list of terms representing clinical and non-clinical concepts. Therefore, rather than users typing “MI” or “myocardial infarction” or misspelling “mlutiople sclerosis”, it allows the mapping of user entered information into concept identifiers.&lt;/p&gt;

&lt;p&gt;Secondly, it provides an understanding to the computer what those concepts actually mean. This allows computer code to understand that “multiple sclerosis” is a type of “demyelinating disease” for example. The relationships within SNOMED-CT essentially provide a database of clinical semantic knowledge.&lt;/p&gt;

&lt;p&gt;These two features mean that SNOMED-CT is a powerful tool in creating modern clinical systems that can not only provide powerful functionality to allow users to record problems, diagnoses and other information but also exchange that information with other systems within the enterprise.&lt;/p&gt;

&lt;p&gt;So how do I use SNOMED-CT within PatientCare?&lt;/p&gt;

&lt;p&gt;Here is a screenshot recording SNOMED-CT in the clinic. For each click, the terms “Injection of botulinum toxin” and the brand (e.g. “dysport”) are recorded within an information model that also records who injected, when and how much.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/patientcare-botox.jpg&quot; alt=&quot;Patientcare Botox&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Importantly, users do not know they are entering SNOMED CT codes when they use these electronic forms.&lt;/p&gt;

&lt;iframe width=&quot;560&quot; height=&quot;315&quot; src=&quot;https://www.youtube.com/embed/Cppjedy-hMo&quot; frameborder=&quot;0&quot; allowfullscreen=&quot;&quot;&gt;&lt;/iframe&gt;

&lt;p&gt;If you would like to see a demonstration of entering clinical information in this way, try my &lt;a href=&quot;https://msdata.org.uk/apps/WebObjects/SnomedBrowser.woa/&quot;&gt;online demo application&lt;/a&gt;. It is very simple, but it shows you how entered free text can be mapped quickly and efficiently.&lt;/p&gt;

&lt;hr /&gt;
&lt;h1 id=&quot;5-design-for-the-future&quot;&gt;5. Design for the future&lt;/h1&gt;

&lt;p&gt;When I sat down to design the architecture that underpins the PatientCare EPR, I planned for a future in which I would combine multiple disparate sources of information to build a complete picture of a single patient and groups of patients.&lt;/p&gt;

&lt;p&gt;I viewed the overall flow of data like this:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/cis_design/data_pipelines.png&quot; alt=&quot;Data Pipelines&quot; /&gt;&lt;/p&gt;

&lt;p&gt;As I write, I now have completed almost all of the modules required in this schematic. I don’t yet have any apps on any app store for patients to use directly, but am piloting clinic-based applications to record patient-reported outcome measures and consent to research.&lt;/p&gt;

&lt;p&gt;As a result, we are now able to see a combined view of data from multiple sources:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/seizure-frequency.png&quot; alt=&quot;Seizure Frequency&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Here we see a patient’s seizures together with their drug regime over time. This is not computerised decision-making, but the computer making the &lt;em&gt;right information available at the right time&lt;/em&gt;.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/pd-data.png&quot; alt=&quot;Pd Data&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Here we see the structured data recorded for a patient with Parkinson’s disease. Instead of trying to capture data from free-text, we record structured data in an efficient way and then generate our summary correspondence from that:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/pd-data-letter.png&quot; alt=&quot;Pd Data Letter&quot; /&gt;&lt;/p&gt;

&lt;p&gt;I have added a complete REST API to allow other applications to liberate the data held within the PatientCare EPR to authorised users or their agents, but there are very few other systems that have adopted either a standardised information model or terminology. The clinical documents that are created are not simply binary blobs of data with unstructured information, but carefully modelled documents with links to the users, the locations, the type of encounter, the diagnoses, medications and procedures, coded and structured. Unfortunately, there are few other systems that can leverage that information yet.&lt;/p&gt;

&lt;p&gt;In this video, I build an electronic consent form within the web-based EPR. An iPad application connects to the EPR using a REST API, downloads the consent form and information about a research project and, while recording patient outcomes directly from the patient, also asks them whether they want to sign-up. Their consent and their outcome measures are then immediately sent back into the EPR and are incorporated into the generated clinical correspondence.&lt;/p&gt;

&lt;iframe width=&quot;560&quot; height=&quot;315&quot; src=&quot;https://www.youtube.com/embed/59tGM85zzlY&quot; frameborder=&quot;0&quot; allowfullscreen=&quot;&quot;&gt;&lt;/iframe&gt;

&lt;p&gt;The last video demonstrates the working of the EPR in the motor neurone disease clinic.&lt;/p&gt;

&lt;iframe width=&quot;560&quot; height=&quot;315&quot; src=&quot;https://www.youtube.com/embed/DGvCzfhOoN0&quot; frameborder=&quot;0&quot; allowfullscreen=&quot;&quot;&gt;&lt;/iframe&gt;

&lt;h1 id=&quot;statistics&quot;&gt;Statistics&lt;/h1&gt;

&lt;ul&gt;
  &lt;li&gt;Over 60,000 lines of code&lt;/li&gt;
  &lt;li&gt;9 years of “spare time” development (evenings and weekends)&lt;/li&gt;
  &lt;li&gt;3000 clinical encounters recorded every month by hundreds of users for direct patient care and clinical research&lt;/li&gt;
  &lt;li&gt;Over 20,000 patients and their outcomes&lt;/li&gt;
  &lt;li&gt;Running on a Linux server sitting in an NHS Wales data centre.&lt;/li&gt;
&lt;/ul&gt;

&lt;h1 id=&quot;my-future-plans&quot;&gt;My future plans&lt;/h1&gt;

&lt;p&gt;I have worked single-handedly on this software for many years but now find myself turning away people who want to use the system as I do not have time to add new functionality and offer support outside of Wales. I have dabbled with outsourcing and subcontracting development work but I would really love to work with others on solving problems in healthcare using information technology.&lt;/p&gt;

&lt;p&gt;Therefore, if you are interested in business development or a partnership or are an IT developer who doesn’t simply want to work on a contract basis, but is interested in what I’m trying to do, I’d be interested in hearing from you. I have some recurring income from the software (from the NHS) which can pay for part-time salaries in the short-term but I think the goal would be to work on seeking investment and then really trying to grow the business. Perhaps it is better as a social enterprise, a charity or a for-profit company. I’m open to ideas. Let me know!&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Mark&lt;/em&gt;&lt;/p&gt;</content><author><name></name></author><summary type="html">The PatientCare electronic patient record system is a web-based application accessible across NHS Wales that records diagnostic, treatment and interventional treatment. It is underpinned by SNOMED-CT, a modern sophisticated and comprehensive terminology system that acts as the ‘lingua franca’ to provide algorithmic understanding and dynamic functionality. While the main functionality is available via a web-based portal, users can also interact with the software using bespoke iPhone and iPad applications.</summary></entry><entry><title type="html">Using SNOMED CT to understand</title><link href="https://www.wardle.org/clinical-informatics/2017/05/20/using-snomed-ct.html" rel="alternate" type="text/html" title="Using SNOMED CT to understand" /><published>2017-05-20T10:15:00+01:00</published><updated>2017-05-20T10:15:00+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/05/20/using-snomed-ct</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/05/20/using-snomed-ct.html">&lt;p&gt;I think that many clinicians have made some fundamental incorrect conclusions about the use of SNOMED CT in clinical practice. In particular, as SNOMED CT is touted as a replacement for Read codes, widely used in general practice in the UK, it is easy to conclude that SNOMED CT adds complexity and redundant codes without adding any other value.&lt;/p&gt;

&lt;p&gt;I have written a short introduction on SNOMED CT in my &lt;a href=&quot;/cis-design/2017/05/02/data-standards.html&quot;&gt;data standards blog post&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;I would like you to understand and appreciate the benefit of the structure of SNOMED CT. To do this, I’m going to give a simple example of how we can leverage the structures built into SNOMED CT to create something useful.&lt;/p&gt;

&lt;h1 id=&quot;snomed-ct-structure&quot;&gt;SNOMED CT structure&lt;/h1&gt;

&lt;p&gt;Fundamentally, SNOMED-CT is broken down into three entities - “Concepts”, “Descriptions” and “Relationships”. A concept represents a concept, which might be a clinical diagnosis, an occupation, a pharmaceutical product or anything else really. Concepts may be simple “multiple sclerosis” or represent compound terms “family history of multiple sclerosis”. Each concept has a number of “Descriptions”, one of which is the preferred term for that language and the others synonyms for that term.&lt;/p&gt;

&lt;p&gt;It is in the “Relationships” that I shall focus today. Relationships link concepts in a directional manner. However, the type of relationship is also a concept. I have shown this diagrammatically:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/snomed-relationship-structure.png&quot; alt=&quot;Snomed Relationship Structure&quot; /&gt;&lt;/p&gt;

&lt;p&gt;This means that multiple sclerosis IS-A type of demyelinating disease.&lt;/p&gt;

&lt;p&gt;Now there are many practical uses of such a structure. One simple use is to understand the types of patients who present to your emergency department. You can iterate through the episodes of care, asking SNOMED-CT to tell you whether the final diagnosis was, for example, a type of respiratory illness.&lt;/p&gt;

&lt;p&gt;To demonstrate the utility of the relationship structure within SNOMED CT, I would like to introduce the solution to a new problem:&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;Can we allow free-text searching of unstructured clinical documents for specific diagnoses, including synonyms of that diagnosis?&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;So what I want to do is allow the user to type, say “MI” and return documents that contain that concept. The simple option is to free-text search for “MI” but that won’t catch documents containing the text “myocardial infarction” or “heart attack”. Can we use the relationships within SNOMED CT to do this?&lt;/p&gt;

&lt;p&gt;Yes you can, and I implemented this a few years ago.&lt;/p&gt;

&lt;p&gt;The solution is:&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;Search for synonyms matching the user entered term (e.g. “MI”). This should return diagnostic concepts matching myocardial infarction but also mitral valve incompetence.&lt;/li&gt;
  &lt;li&gt;For each synonym, find the concept. For each concept, optionally also find concepts that are equivalent “child” concepts, recursively walking the IS-A relationship tree.&lt;/li&gt;
  &lt;li&gt;For each concept, return all of the descriptions.&lt;/li&gt;
&lt;/ol&gt;

&lt;p&gt;An example can be found here, hitting a live SNOMED CT REST terminology server.&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/synonyms?s=mi&amp;amp;root=64572001&amp;amp;fsn=false&amp;amp;inactive=false&quot;&gt;http://msdata.org.uk:8080/snomedct/synonyms?s=mi&amp;amp;root=64572001&amp;amp;fsn=false&amp;amp;inactive=false&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;You should end up with JSON with your results:&lt;/p&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;&lt;span class=&quot;p&quot;&gt;{&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;data&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Heart attack&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Cardiac infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Infarction of heart&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Myocardial infarct&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Mitral incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MR - Mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;AMI - Acute myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Coronary thrombosis not resulting in myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Myocardial infarction aborted&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Aborted myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Silent myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Silent myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;NSTEMI - Non-ST segment elevation MI&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction due to left coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation MI (myocardial infarction) due to left coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction due to right coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation MI (myocardial infarction) due to right coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;],&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;total&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;26&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;}&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;If I turn on support for returning synonyms of child concepts as well, then we end up with a very comprehensive list of search terms:&lt;/p&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;&lt;span class=&quot;p&quot;&gt;{&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;data&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of basal-lateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral stenosis with regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral stenosis with incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral stenosis with insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Healed coronary&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Old myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Healed myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute papillary muscle infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute infarction of papillary muscle&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of posterolateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Myocardial infarct&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Infarction of heart&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Cardiac infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Heart attack&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction with rupture of ventricle&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral incompetence - rheumatic&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Past myocardial infarction diagnosed on electrocardiogram AND/OR other special investigation, but currently presenting no symptoms&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Past myocardial infarction diagnosed on ECG AND/OR other special investigation, but currently presenting no symptoms&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Microinfarction of heart&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Microinfarct of heart&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MR - Mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Mitral incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anteroapical myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anteroapical infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anterior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;AMI - Acute myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute lateral myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of lateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of apical-lateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral AND aortic valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral AND aortic valve incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral AND aortic valve insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anteroseptal myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of high lateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of inferolateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute inferolateral myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of anterolateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anterolateral myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute subendocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute nontransmural infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of posterobasal wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of diaphragmatic wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute inferior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute inferoposterior infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of inferoposterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of septum alone&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute septal infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of septum&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rheumatic mitral valve insufficiency AND aortic valve stenosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postoperative myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral stenosis with insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral stenosis with regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral stenosis with incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral incompetence and aortic stenosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral regurgitation and aortic stenosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral insufficiency and aortic stenosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral and aortic incompetence&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral and aortic insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral and aortic regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;True posterior wall infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;True posterior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of atrium&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute atrial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Aborted myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Myocardial infarction aborted&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Coronary thrombosis not resulting in myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Reinfarction of myocardium&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent myocardial infarction of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent myocardial infarction of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Non-rheumatic mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral incompetence, non-rheumatic&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave infarction - anteroseptal&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction - anteroseptal&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave infarction - anterolateral&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction - anterolateral&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave infarction - inferior&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction - inferior&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave infarction - inferolateral&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction - inferolateral&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave infarction - lateral&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction - lateral&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute widespread myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave infarction - widespread&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction - widespread&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute posterior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Old anterior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Old inferior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Old lateral myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Old posterior myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Silent myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MI - Silent myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral regurgitation due to dysfunct subvalvular apparatus&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Functional mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Prosthetic mitral valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q wave myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute Q-wave infarct&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-Q wave infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postoperative transmural myocardial infarction of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postoperative transmural myocardial infarction of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postoperative subendocardial myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Non-Q wave myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Myocardial infarction with complication&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute mitral regurgitation from chordal rupture&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute mitral regurgitation from chordal dysfunction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute mitral regurgitation from papillary muscle dysfunction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute mitral regurgitation from papillary muscle rupture&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;First myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;STEMI - ST elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;NSTEMI - Non-ST segment elevation MI&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Myocardial infarction in recovery phase&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mixed myocardial ischaemia and infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mixed myocardial ischemia and infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Regurgitation of fetal mitral valve&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Regurgitation of foetal mitral valve&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute STEMI (ST elevation myocardial infarction) of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anterior ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute anterior ST segment elevation myocardial infarction with right ventricular involvement&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute STEMI (ST elevation myocardial infarction) of anterior wall with right ventricular involvement&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of anterior wall involving right ventricle&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Prosthetic mitral valve stenosis and regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral prosthetic valve stenosis and regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute prosthetic mitral valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute mitral prosthetic valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent inferior ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent ST segment elevation myocardial infarction of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent STEMI (ST elevation myocardial infarction) of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent STEMI (ST elevation myocardial infarction) of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent ST segment elevation myocardial infarction of anterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent anterior ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent STEMI (ST elevation myocardial infarction)&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction during procedure&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute periprocedural myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute STEMI (ST elevation myocardial infarction) of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute inferior ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of inferior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postprocedural mitral regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postprocedural mitral valve regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of inferior wall involving right ventricle&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of inferior wall with right ventricular involvement&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of anterior wall involving right ventricle&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction of anterior wall with right ventricular involvement&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of inferior wall involving right ventricle&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute inferior ST segment elevation myocardial infarction with right ventricular involvement&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute STEMI (ST elevation myocardial infarction) of inferior wall with right ventricular involvement&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation due to cardiomyopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Non-rheumatic mitral valve stenosis with insufficiency&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Non-rheumatic mitral valve stenosis with regurgitation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral regurgitation due to acute myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation due to acute myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral regurgitation due to infiltrative disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation due to infiltrative disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation due to acute myocardial infarction without papillary muscle and chordal rupture&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Mitral valve regurgitation due to acute myocardial infarction with papillary muscle and chordal rupture&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postprocedural mitral regurgitation due to papillary muscle and chordal damage&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postprocedural mitral valve regurgitation due to papillary muscle and chordal rupture&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent non-ST segment elevation myocardial infarction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subsequent NSTEMI (non-ST segment elevation myocardial infarction)&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction due to left coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute myocardial infarction due to right coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction involving left anterior descending coronary artery&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction involving left main coronary artery&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of posterolateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of anterolateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of lateral wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of anteroseptal wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of posterior wall&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation MI (myocardial infarction) due to left coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction due to left coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation MI (myocardial infarction) due to right coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction due to right coronary artery occlusion&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of septum&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute ST segment elevation myocardial infarction of posterobasal wall&quot;&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;],&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;total&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;191&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;}&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;We could then use these results to maximise finding our search term in our unstructured corpus of documents.&lt;/p&gt;

&lt;p&gt;Look what we get if we now search for “demyelinating disease”:&lt;/p&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;&lt;span class=&quot;p&quot;&gt;{&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;data&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease, type IC&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Demyelinating disease of central nervous system&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Demyelinating disorders of the central nervous system&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Demyelinating CNS disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Demyelinating disease central nervous system (CNS)&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Central pontine myelinolysis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leukoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multifocal leukoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;PML - Progressive multifocal leukoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leucoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multifocal leucoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;PML - Progressive multifocal leucoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;PMLE - Progressive multifocal leukoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;PMLE - Progressive multifocal leucoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Disseminated sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MS - Multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;DS - Disseminated sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Optic neuromyelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Neuromyelitis optica&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subacute myelo-optic neuropathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;SMON - subacute myelo-optico-neuropathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Devic syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Devic's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease, type IA&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease, type IB&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Diffuse sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Schilder's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Encephalitis periaxialis diffusa&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Schilder disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute hemorrhagic leukoencephalitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Hurst's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute hemorrhagic leukoencephalitis of Weston Hurst&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute haemorrhagic leucoencephalitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute haemorrhagic leucoencephalitis of Weston Hurst&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;ADEM - Acute disseminated encephalomyelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute disseminated encephalomyelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Binswanger's encephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subcortical arteriosclerotic encephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subcortical atherosclerotic dementia&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Chronic progressive subcortical encephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subcortical leukoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Binswanger's dementia&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Encephalitis subcorticalis chronica&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Binswanger's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subcortical leucoencephalopathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Brain stem multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis of the brainstem&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis of the spinal cord&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Generalized multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Generalised multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Exacerbation of multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis (MS) exacerbation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute relapsing multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Chronic progressive multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis (MS) chronic/progressive&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Remittent-progressive multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis (MS) remitting progressive&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Extrapontine myelinolysis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute demyelinating transverse myelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute non-infective transverse myelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subacute necrotising myelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Subacute necrotizing myelitis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Balo's concentric sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Balo concentric sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Concentric sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Balos concentric sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Chronic inflammatory demyelinating polyradiculoneuropathy with central nervous system demyelination&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Demyelination of spinal cord&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Spinal demyelination&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Marchiafava-Bignami disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Central demyelination of corpus callosum&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Marchiafava disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Hereditary sensory-motor neuropathy, type I&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Peroneal muscular atrophy of demyelinating type&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Inherited dominant hypertrophic neuropathy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Hereditary motor and sensory neuropathy type I&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease of demyelinating type&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;HSMN, type I&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease, type I&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot Marie Tooth disease, type 1&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leukoencephalopathy associated with AIDS&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leucoencephalopathy associated with AIDS&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leukoencephalopathy associated with acquired immunodeficiency syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leucoencephalopathy associated with acquired immunodeficiency syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Central nervous system demyelinating disease associated with AIDS&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Central nervous system demyelinating disease associated with acquired immunodeficiency syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Secondary progressive multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis (MS) secondary progressive&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Relapsing remitting multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis (MS) relapsing remitting&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Primary progressive multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multiple sclerosis (MS) primary progressive&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Benign multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Malignant multiple sclerosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Clinically isolated syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Vanishing white matter disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;LBSL - Leukoencephalopathy with brainstem and spinal cord involvement with lactate elevation&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Multifocal clinically isolated syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Polysymptomatic clinically isolated syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Monofocal clinically isolated syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leukoencephalopathy co-occurrent with human immunodeficiency virus infection&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Progressive multifocal leucoencephalopathy co-occurrent with human immunodeficiency virus infection&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Demyelinating disease of central nervous system co-occurrent with human immunodeficiency virus infection&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease and deafness&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease type 1E&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Charcot-Marie-Tooth disease type IE&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Acute disseminated encephalomyelitis following infectious disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;[X]Other specified acute disseminated demyelination&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;[X]Acute disseminated demyelination, unspecified&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Uhthoff's syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Uhthoff phenomenon&quot;&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;],&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;total&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;113&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;}&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;

&lt;p&gt;And can we find patients with something related to Parkinsonism? Let’s ask SNOMED CT for the terms to search for….&lt;/p&gt;

&lt;div class=&quot;highlighter-rouge&quot;&gt;&lt;pre class=&quot;highlight&quot;&gt;&lt;code&gt;&lt;span class=&quot;p&quot;&gt;{&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;data&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Ethopropazine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by ethopropazine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by profenamine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by ethopropazine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by profenamine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism due to drug&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism caused by drug&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Antiparkinsonian drug poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by anti-parkinsonism drug&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by anti-parkinsonism drug&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Methylphenyltetrahydropyridine-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MPTP-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;MPTP - Methylphenyltetrahydropyridine-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Postencephalitic parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;SND - Striatonigral degeneration&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Striatonigral degeneration&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Striatonigral atrophy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Amantadine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by amantadine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by amantadine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Disorders presenting primarily with parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Syphilitic parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Idiopathic Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;PD - Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Paralysis agitans&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Shaking palsy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Primary Parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Idiopathic Parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsons disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinson-dementia complex of Guam&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinson's disease - dementia complex on Guam&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonian syndrome associated with idiopathic orthostatic hypotension&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonian syndrome associated with symptomatic orthostatic hypotension&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Neuroleptic-induced Parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Neuroleptic-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Diphenhydramine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by diphenhydramine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by diphenhydramine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Levodopa poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by levodopa&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by L-dopa&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by L-dopa&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by levodopa&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning by anticonvulsant AND/OR anti-Parkinsonism drug&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Poisoning caused by anticonvulsant AND/OR anti-Parkinsonism drug&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism with orthostatic hypotension&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental amantadine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental poisoning by amantadine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental poisoning caused by amantadine&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Juvenile Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Juvenile Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Secondary Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Secondary Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Secondary parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Carbon monoxide-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Manganese-induced parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism with calcification of basal ganglia&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Vascular parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Symptomatic parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Anticonvulsant and antiParkinsonian drug poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental levodopa poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional levodopa poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Levodopa poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional amantadine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Amantadine poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lisuride poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lysuride poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental lisuride poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental lysuride poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional lisuride poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional lysuride poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lisuride poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lysuride poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Bromocriptine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental bromocriptine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional bromocriptine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Bromocriptine poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental ethopropazine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional ethopropazine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Ethopropazine poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Decarboxylase inhibitor poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Selegiline poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental selegiline poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional selegiline poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Selegiline poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental diphenhydramine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional diphenhydramine poisoning&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Diphenhydramine poisoning of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Dopaminergic drug used in parkinsonism adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Adverse reaction to levodopa, L-dopa&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Levodopa adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Co-beneldopa adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Benserazide + levodopa adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Co-careldopa adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Carbidopa + levodopa adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Amantadine adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Apomorphine adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lisuride adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lysuride adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Pergolide adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Bromocriptine adverse reaction&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Dopaminergic drug used in parkinsonism allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Levodopa allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Co-beneldopa allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Benserazide + levodopa allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Co-careldopa allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Carbidopa + levodopa allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Amantadine allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Apomorphine allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lisuride allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lysuride allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Pergolide allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Bromocriptine allergy&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Overdose of dopaminergic drug used in parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Levodopa overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental levodopa overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional levodopa overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Levodopa overdose of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Amantadine overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental amantadine overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional amantadine overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Amantadine overdose of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lisuride overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lysuride overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental lysuride overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental lisuride overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional lisuride overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional lysuride overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lisuride overdose of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lysuride overdose of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Bromocriptine overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Accidental bromocriptine overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Intentional bromocriptine overdose&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Bromocriptine overdose of undetermined intent&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;On - off phenomenon&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Dystonia musculorum deformans&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Lubag&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;XDP - X-linked dystonia parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;X-linked torsion dystonia parkinsonism syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;X-linked dystonia parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Torsion dystonia parkinsonism Filipino type&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Perry syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism with alveolar hypoventilation and mental depression&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Rapid onset dystonia parkinsonism&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;DYT12 - dystonia 12&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Dystonia 12&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Familial Pick's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Frontotemporal dementia with parkinsonism-17&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Wilhelmsen-Lynch disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Disinhibition-dementia-parkinsonism-amytrophy complex&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;FTDP-17 - Frontotemporal dementia with parkinsonism 17&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Young onset Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Early onset Parkinson's disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Early onset Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Young onset Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism co-occurrent with dementia of Guadeloupe&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Parkinsonism with dementia of Guadeloupe&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Waisman syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Laxova Opitz syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Early onset parkinsonism and intellectual disability syndrome&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Hereditary late onset Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Autosomal dominant late onset Parkinson disease&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Infantile bilateral striatal necrosis&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
    &lt;/span&gt;&lt;span class=&quot;s2&quot;&gt;&quot;Infantile striatonigral degeneration&quot;&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;p&quot;&gt;],&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
  &lt;/span&gt;&lt;span class=&quot;nt&quot;&gt;&quot;total&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;&lt;span class=&quot;w&quot;&gt; &lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;169&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;}&lt;/span&gt;&lt;span class=&quot;w&quot;&gt;
&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;
&lt;/div&gt;</content><author><name></name></author><summary type="html">I think that many clinicians have made some fundamental incorrect conclusions about the use of SNOMED CT in clinical practice. In particular, as SNOMED CT is touted as a replacement for Read codes, widely used in general practice in the UK, it is easy to conclude that SNOMED CT adds complexity and redundant codes without adding any other value.</summary></entry><entry><title type="html">Google DeepMind Caldicott letter</title><link href="https://www.wardle.org/clinical-informatics/2017/05/10/caldicott.html" rel="alternate" type="text/html" title="Google DeepMind Caldicott letter" /><published>2017-05-10T11:55:00+01:00</published><updated>2017-05-10T11:55:00+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/05/10/caldicott</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/05/10/caldicott.html">&lt;blockquote&gt;
  &lt;p&gt;Google Deepmind may have received the personally identifying medical records of million NHS patients on a legally inappropriate basis&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;&lt;a href=&quot;https://twitter.com/skynewstonight/status/864183833960235014&quot;&gt;Sky News, 15th May 2017&lt;/a&gt;&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;Taking into account what you have now clarified, it is my view and that of my panel that the purpose for the transfer of 1.6 million identifiable patient records to Google DeepMind was for the testing of the Streams application, and not for the provision of direct care to patients. Given that Streams was going through testing and therefore could not be relied upon for patient care, any role the application might have played in supporting the provision of direct care would have been limited and secondary to the purpose of the data transfer. My considered opinion therefore remains that it would not have been within the reasonable expectation of patients that their records would have been shared for this purpose.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;h2 id=&quot;dame-fiona-caldicott-national-data-guardian-february-2017&quot;&gt;&lt;a href=&quot;https://twitter.com/lexanderjmartin/status/864183460478541825&quot;&gt;Dame Fiona Caldicott, National Data Guardian, February 2017&lt;/a&gt;&lt;/h2&gt;

&lt;h1 id=&quot;trust-and-openness&quot;&gt;Trust and openness&lt;/h1&gt;

&lt;p&gt;Fundamentally, this is about trust and openness. It is what is reasonable and expected.&lt;/p&gt;

&lt;p&gt;However, while that’s quite easy to say, who decides what is reasonable and expected? Do you know how your medical information is stored and to whom they are shared? For example, would you expect an IT supplier to potentially have access to your information?&lt;/p&gt;

&lt;p&gt;Here is an extract from a contract between a UK health organisation and an IT system supplier (and it is not the Google DeepMind contract):&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;&lt;em&gt;Personal data and medical records.&lt;/em&gt; The Supplier shall at all times comply with the Data Protection Legislate. In particular the Supplier acknowledges that in the course of providing the Works and/or Services it may access Personal Data. As needed the Supplier undertakes: a) to maintain technical and organisational security measures sufficient to comply at least with the obligations imposed on the Trust by the Seventh Data Protection Principle; b) only to process Personal Data for and on behalf of the Trust, in accordance with the instructions of the Trust and for the purpose of performance of the; c) to allow the Trust to audit the Supplier’s compliance with the requirements of this Clause on reasonable notice and/or to provide the Trust with evidence of its compliance with the obligations set out in this Clause.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Indeed, the Royal Free have published a useful video on how patient information may be used within an organisation and with suppliers who are acting &lt;em&gt;for and on behalf&lt;/em&gt; of them:&lt;/p&gt;

&lt;iframe width=&quot;560&quot; height=&quot;315&quot; src=&quot;https://www.youtube.com/embed/VgpzDYStjm0&quot; frameborder=&quot;0&quot; allowfullscreen=&quot;&quot;&gt;&lt;/iframe&gt;

&lt;p&gt;It is therefore clear that a large health organisation will use patient information for direct clinical care but will share those data when appropriate when other organisations or suppliers are acting “for and on behalf” of them to support the care of patients.&lt;/p&gt;

&lt;p&gt;I’m surprised by the level of criticism on Twitter this evening and impressed by the balanced view given by the Sky News item. Dame Caldicott has written to the Information Commissioner’s Office (ICO) to raise her concerns. There will be an investigation from the ICO who will make a decision regarding whether data sharing was appropriate or not.&lt;/p&gt;

&lt;h1 id=&quot;what-is-testing&quot;&gt;What is “testing”?&lt;/h1&gt;

&lt;p&gt;The issue at hand appears to be the use of patient data to test a software application. Dame Caldicott opines that as data were transferred for testing, then such transfer was unreasonable.&lt;/p&gt;

&lt;p&gt;To make a judgement on this matter, one needs to understand the law relating to confidential information, the information governance principles and software development. 
The &lt;a href=&quot;https://www.gov.uk/data-protection/the-data-protection-act&quot;&gt;Data Protection Act&lt;/a&gt; requires that data be used fairly and lawfully in a way that is adequate, relevant and not excessive. 
The &lt;a href=&quot;http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4068403&quot;&gt;first Caldicott Committee report&lt;/a&gt; was released in 1997 and stipulated six key principles for information governance. The &lt;a href=&quot;https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/192572/2900774_InfoGovernance_accv2.pdf&quot;&gt;second report&lt;/a&gt; refined these core principles and emphasised the difference between implicit consent for direct patient care and explicit consent for research. The &lt;a href=&quot;https://www.gov.uk/government/publications/review-of-data-security-consent-and-opt-outs&quot;&gt;third report&lt;/a&gt;, commissioned after the care.data debacle, was published last year and we await an official Government response.&lt;/p&gt;

&lt;h3 id=&quot;is-the-streams-application-for-direct-care&quot;&gt;Is the Streams application for direct care?&lt;/h3&gt;

&lt;p&gt;Therefore, the first question to ask is whether the Streams application is for the direct care of patients?&lt;/p&gt;

&lt;p&gt;The Streams application runs on mobile devices and receives notifications about patients who have developed an acute kidney injury. Such an application needs a considerable underlying infrastructure in order to make it work. Much like an online shopping application on your phone, the actual work occurs in a server in a data centre. When a clinician gets an alert, they can view the patient’s record, including information about admissions, discharges, diagnoses and previous blood results in order to prioritise the care of that patient. It is not simply a notification but a window into the patient record. It is my opinion that this application satisfies the requirements of direct care for patients. Watch the Sky News report and how the consultant nurse describes its use. I am not aware of any serious argument to suggest that it is not for direct care.&lt;/p&gt;

&lt;h3 id=&quot;were-not-buying-a-new-car&quot;&gt;We’re not buying a new car&lt;/h3&gt;

&lt;p&gt;The next consideration is how one builds software that works safely and consistently. In general, the best way of prove that software works correctly is to test it. There are multiple levels of testing in which larger and larger components of a total solution are tested iteratively. If you want to read more, I cover testing in my &lt;a href=&quot;https://www.dropbox.com/s/62sg71a19voxpts/cis_design.pdf?dl=0&quot;&gt;Domain-driven design for clinical information systems document&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;Unit testing checks that a single unit of functionality works as expected, testing the module in isolation to check that the outputs are what one would expect given the specified inputs. It is possible to run these tests every time code is changed and such tests are possible using dummy fake data designed to test how a module performs given both usual and unusual data inputs.&lt;/p&gt;

&lt;p&gt;Integration and system testing test the combination of modules together as well as their interactions with other components within a wider ecosystem. For a simple application with few interactions, integration tests can be straightforward but such testing can be complex and involved when there are multiple different interactions, particularly when those interactions are with other systems that have been created by other vendors.&lt;/p&gt;

&lt;p&gt;It is possible to run such tests in a specific environment for tests in which there are fake ‘mock’ services. For example, one might have a fake patient administration system or a fake laboratory information system running with dummy information in order to test interactions between those systems. However, at some point during application development, the application must be deployed.&lt;/p&gt;

&lt;p&gt;Software applications are not like buying a car. When I go and buy a car, I know that it will work on the road and it will fit onto my drive and I’ll  take care that it’s got the right number of seats for my family. The car design has been tested and quality tests would have been performed before it was ready for purchase. I can buy it and drive it home.&lt;/p&gt;

&lt;p&gt;Instead, software development is much more like teaching your child to ride a bicycle. We can use dummy data like we use stabilisers, but at some point we have to take off those stabilisers! Similarly, at some point, we need to expose our new application to real data.&lt;/p&gt;

&lt;p&gt;Now if you are anything like me when teaching a child to ride a bicycle, you took off the stabilisers and then ran very quickly alongside the child as they wobbled precariously from side-to-side! In the same way, any responsible organisation writing software applications cannot and should not hand over their application without further monitoring and testing to ensure that what you think will work does not work in a live environment. Once in the live environment, it would be unreasonable for a software company to &lt;em&gt;not&lt;/em&gt; perform additional testing to be sure that their software works as expected. Similarly, we run next to our child and check that they are safe and don’t forget to keep on pedalling!&lt;/p&gt;

&lt;h1 id=&quot;conclusions&quot;&gt;Conclusions&lt;/h1&gt;

&lt;p&gt;It is important to have robust scrutiny in relation to the use of patient-identifiable information by third-parties. However, I am surprised that Dame Caldicott has suggested that it might be inappropriate to test software systems designed for direct care with real patient information. I would argue that such testing is necessary in the final stages of development to ensure that new technology is safely deployed in live clinical environments.&lt;/p&gt;</content><author><name></name></author><summary type="html">Google Deepmind may have received the personally identifying medical records of million NHS patients on a legally inappropriate basis</summary></entry><entry><title type="html">Safely deploying machine learning in healthcare</title><link href="https://www.wardle.org/clinical-informatics/2017/05/10/machine-learning.html" rel="alternate" type="text/html" title="Safely deploying machine learning in healthcare" /><published>2017-05-10T11:55:00+01:00</published><updated>2017-05-10T11:55:00+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/05/10/machine-learning</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/05/10/machine-learning.html">&lt;p&gt;In a previous blog post, I have discussed the value of information technology in supporting clinical care, unashamedly stealing and modifying Google’s original mantra:&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;“to organise the world’s information and make it universally accessible and useful”.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;and adapting it to healthcare information:&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;&lt;a href=&quot;/clinical-informatics/2017/03/09/google-information.html&quot;&gt;to organise healthcare information and make it universally accessible and useful&lt;/a&gt;&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;and argued that we should be making healthcare safer by &lt;a href=&quot;/information-governance/2017/03/19/information-governance.html&quot;&gt;running it on rails&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;Now I also regularly argue that we should be routinely recording structured information about our patients including information relating to problems, diagnoses and outcomes. Such data then allows us to make appropriate inferences about our patients such as, how is this patient doing compared to other patients with this condition? In many clinical situations, identifying the patient not behaving as expected is important.&lt;/p&gt;

&lt;p&gt;While machine learning (ML) holds the promise for creating tools that can make such inferences independently or semi-independently, I would argue that information technology can also valuably support care by organising and presenting information about patients to patients and clinicians and providing intuitive adaptive tools that allow the systematic recording of clinical information.&lt;/p&gt;

&lt;p&gt;Such goals may sound mundane compared to the future possibilities of machine learning in healthcare, but to clinicians and patients who have spent many years being “information-poor”, the power of having all relevant information available on hand as well as adaptive tools to record that information quickly and efficiently should not be under-estimated.&lt;/p&gt;

&lt;p&gt;The conclusion is, therefore, that we need clinical information systems that enable health professionals and patients to make inferences and support clinical decision making.&lt;/p&gt;

&lt;h1 id=&quot;machine-learning-for-clinical-decision-making&quot;&gt;Machine learning for clinical decision making&lt;/h1&gt;

&lt;p&gt;The problem with inferences made independently by ML is that we may not be able to, figuratively speaking, open the box and see the logical, sequential arguments and premises used to reach a conclusion. Much as in legal argument or any other form of logical reasoning, carefully crafted reasoning and argument are built upon a framework of assumptions and known evidence. In such reasoning, one can craft inferences upon inferences and justify the final conclusions by examination of each step.&lt;/p&gt;

&lt;p&gt;Human decision making is fallible and frequently non-deterministic with &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057365/&quot;&gt;human error often the source of important errors in healthcare&lt;/a&gt;. Indeed, systems designed to reduce the frequency and impact of human error such as checklists, redundancy, guidelines and protocols are attempts to make human decision making more deterministic and less at risk of bias. Many systems work by breaking down a larger decision or process of care into smaller discrete steps.&lt;/p&gt;

&lt;p&gt;If I see a patient and start them on a new treatment, such as pyridostigmine, you can ask me to justify why I recommended starting this treatment for that patient in clinic and I will be able to give you a logical reasoned argument built upon evidence and inference that will include the presence or absence of particular characteristics. In this case, the characteristics may include knowledge of the diagnosis of myasthenia gravis and the rationale for that diagnosis such as the positive finding of acetylcholine receptor antibodies in the patient’s serum. I may explain the balance between symptomatic treatment such as pyridostigmine and treatments of greater efficacy but risk of adverse effects in arriving at that decision.&lt;/p&gt;

&lt;p&gt;Essentially, I can attempt to demonstrate the correctness of my final decision by a chain of reasoning. Similarly, someone else might be able to conclude I made the wrong decision by examining that chain of reasoning.&lt;/p&gt;

&lt;p&gt;So the logical questions are:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;what are the regulatory requirements within which we must work in order to make effective use of ML in healthcare?&lt;/li&gt;
  &lt;li&gt;do we need to understand how machines arrive at their conclusions, so we can justify using those conclusions in clinical practice?&lt;/li&gt;
  &lt;li&gt;won’t designing  information systems that arrive at their conclusions without justification risk replicating the fallibility of human decision making?&lt;/li&gt;
  &lt;li&gt;must we be able to &lt;em&gt;see inside the box&lt;/em&gt;?&lt;/li&gt;
  &lt;li&gt;can augmented ML decision support processes be decomposed into discrete steps with the results of one semi-deterministic “black-box” feeding the action of another? Does such decomposition result in creating a partial ‘window’ to allow us to understand the chain of reasoning created by ML devices?&lt;/li&gt;
  &lt;li&gt;and finally, how can we introduce machine learning in a safe and incremental manner in healthcare?&lt;/li&gt;
&lt;/ul&gt;

&lt;h1 id=&quot;medical-devices&quot;&gt;“Medical devices”&lt;/h1&gt;

&lt;p&gt;The Medicines &amp;amp; Healthcare Regulatory Agency (MHRA) provides &lt;a href=&quot;https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/610189/Software_flow_chart_Ed_1-03.pdf&quot;&gt;helpful advice on the certification of software used in healthcare&lt;/a&gt;. That interactive PDF will take you step-by-step through a decision aid in order to determine whether your software meets the definition of a “medical device”, and needs certification and accreditation with a declaration of conformity (“CE” marking).&lt;/p&gt;

&lt;p&gt;The guidance is logically organised and intuitive except that the section on “medical purpose” needs to be read carefully. Many things that you might think have a “medical purpose” are not included in their definition. This is important as if your software has a “medical purpose”, then essentially it needs assessment and certification as a medical device.&lt;/p&gt;

&lt;p&gt;For example, software which independently makes a diagnosis based on imaging data would satisfy the test for “medical purpose” and therefore be labelled a medical device. However, software which displays data and makes general recommendations is not a medical device. Software or devices which monitor sport or fitness are not medical devices, but would be considered as such if they were intended for use to monitor physiological parameters that will affect the treatment of a patient.&lt;/p&gt;

&lt;p&gt;If software claims to do any of the following, then it does have a “medical purpose”:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;make recommendations to seek further advice based on user entered data.&lt;/li&gt;
  &lt;li&gt;indicate the risk that a specific patient has of developing a disease based on entered data for that patient.&lt;/li&gt;
  &lt;li&gt;allow remote access to information on physical monitors and applies user-defined filtering rules to any alarms generated by the original device.&lt;/li&gt;
  &lt;li&gt;monitor a patient and collects information entered by the user, measured automatically by the app or collected by a point of care device may qualify as a medical device if the output is intended to affect the treatment of an individual.&lt;/li&gt;
  &lt;li&gt;automate the treatment pathway for an individual patient.&lt;/li&gt;
  &lt;li&gt;provide clinical decisions&lt;/li&gt;
  &lt;li&gt;intended for therapeutic drug monitoring&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;However, if software has only one of these purposes, then it is not considered as having a “medical purpose”:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Patient medical education&lt;/li&gt;
  &lt;li&gt;Monitors fitness/health/wellbeing&lt;/li&gt;
  &lt;li&gt;Professional medical education&lt;/li&gt;
  &lt;li&gt;Stores or transmits medical data without change&lt;/li&gt;
  &lt;li&gt;Software that is used to book an appointment, request a prescription or have a virtual consultation is also unlikely to be considered a medical device if it only has an administrative function.&lt;/li&gt;
  &lt;li&gt;Software that provides reference information to help a Healthcare Professional to use their knowledge to make a clinical decision.&lt;/li&gt;
  &lt;li&gt;Data or databases for storing data&lt;/li&gt;
&lt;/ul&gt;

&lt;h1 id=&quot;implications-for-information-technology&quot;&gt;Implications for information technology&lt;/h1&gt;

&lt;p&gt;The process of confirmation of conformity with the requirements of a “medical device” is confirmation that it passes &lt;a href=&quot;http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1993L0042:20071011:EN:PDF&quot;&gt;clinical evaluation&lt;/a&gt;. This process is designed to verify that a device performs as it is intended to do so, requiring research to demonstrate efficacy and adverse effect risk, much like the evaluation of a pharmaceutical product. There is a lot of information from MHRA on the &lt;a href=&quot;https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/508494/Guidance_for_mfrs_on_clinical_trials__GN1__-_16_Mar_2016.pdf&quot;&gt;clinical evaluation of medical devices&lt;/a&gt; available online. In addition, any device needs ongoing surveillance of its functionality in order to confirm that it continues to function as it was intended and has had no untoward effects not found during clinical evaluation.&lt;/p&gt;

&lt;p&gt;Most information technology systems are made up of multiple interoperating modules and it is unlikely that all such modules would meet the criteria to become medical devices. As a result, it is possible for the accreditation to be needed for a single module.&lt;/p&gt;

&lt;p&gt;The natural conclusion is to plan for two parallel streams of work in relation to machine learning.&lt;/p&gt;

&lt;p&gt;The first stream is to support the ascertainment, aggregation and presentation of data relating to patients in order to support clinical care. Such data might range from the results from laboratory tests to links to guidelines that might apply in that general clinical context. This stream of work will not meet the criteria for a “medical device” and yet ML offers opportunities to improve how information is recorded, retrieved and shown. Importantly, I’d argue that the graphical display of data is under-used in healthcare and yet is a powerful way of summarising information without inadvertently creating a device that needs accreditation as a medical device.&lt;/p&gt;

&lt;p&gt;The second stream is the development of software that can independently make inferences and judgements and present those results in order to influence or change patient management. Such software would be categorised as a “medical device”, and as a result, this stream of work must be undertaken much as the development of a new pharmacological product, via a phased and iterative structured research programme. The four phases for pharmaceutical products are:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;
    &lt;p&gt;Phase I studies the safety of the product, with testing on small numbers of healthy volunteers.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;Phase II studies the efficacy of the product usually by randomising individuals to either placebo or the pharmaceutical product and assessing the difference. In clinical situations in which there is an established treatment, the control arm of the study would typically involve the “current standard of care or treatment” rather than placebo.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;Phase III is essentially a large scale version of Phase II but patients are almost always randomised. Phase III results can be used to seek MHRA approval for the use of that product.&lt;/p&gt;
  &lt;/li&gt;
  &lt;li&gt;
    &lt;p&gt;Phase IV is the post-marketing surveillance, monitoring the real-world use of the product.&lt;/p&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;h3 id=&quot;clinical-research-for-medical-devices&quot;&gt;Clinical research for medical devices&lt;/h3&gt;

&lt;p&gt;However, this scheme is modified for medical devices which need to prove safety and performance (as claimed) rather than efficacy. This distinction is made in the &lt;a href=&quot;http://www.hra.nhs.uk/documents/2013/09/approval-of-medical-devices-research-version-2-april-2008.pdf&quot;&gt;UK’s National Patient Safety Agency (NPSA) National Research Ethics Service (NRES) guidance&lt;/a&gt; from 2008. Assessment of safety requires studies to determine whether there are any “undesirable side effects under normal conditions of use and to allow an informed clinical opinion to assess whether these are acceptable when weighed against the benefits in relation to the intended performance of the device.” Assessment of performance requires studies “to verify that under normal conditions of use the performance characteristics of the device are those intended by the manufacturer.”&lt;/p&gt;

&lt;p&gt;Just because a study is required to demonstrate safety and performance, the nature of ML devices is that such studies may not necessarily have to be performed prospectively. Indeed, a simple ML device that is claimed to, for example, recognise a deteriorating renal function, may simply require a study of performance against retrospective clinical data in order to verify that it is performing as required; this is an &lt;em&gt;in-silico trial&lt;/em&gt;. It is important to note that such a process would need to be repeated if the device or its logic changed but this would be straightforward if the device to be tested simply needs to process the validation dataset and have its results checked. Indeed, this is the very essence of test-driven development in which a set of tests are written to validate that a piece of software is correct. The logical conclusions that follow from a need to perform both ML training and then subsequent validation is the provision of large-scale real clinical datasets.&lt;/p&gt;

&lt;p&gt;However, is it possible to reduce the assessment of a medical device to a process of validation of the outputs given the specified inputs?&lt;/p&gt;

&lt;p&gt;In many cases it is, particularly where the scope of the problem to be solved is limited or, a more complex problem has been decomposed manually in a series of steps and each of those steps can be tested independently. It really doesn’t matter if the process performed in each step is opaque as long as we can validate the output given a range in inputs. To answer one of our questions: we don’t have to “see inside the box”. I’d regard these as &lt;em&gt;bounded problems&lt;/em&gt; in which human supervision has carefully curated the data used as input. In essence, the ML is a supervised process and is functioning much as one would apply regression to a set of data in order to determine the covariates that significantly effect the outcome.&lt;/p&gt;

&lt;p&gt;However, what if the inputs and outputs are much more complex and less bounded? In complex medical environments, there may be data relating to a range of parameters such as co-morbidities, patient location, previous admissions, laboratory test results etc. Any or all of these data may be potentially used as input for deep-learning training and may produce random and sometimes bizarre outputs unexpectedly in a minority of situations. The ‘black-box’ inferences resulting from a hypothesis-free unbounded, unsupervised training paradigm using large amounts of clinical data cannot be explained or validated easily. In these circumstances, a model may use unexpected pieces of data made available as part of training in order to derive the outputs. This is particularly important for data that is not a predictive factor for an outcome, but a result of that outcome.&lt;/p&gt;

&lt;p&gt;For example, this might result in inappropriate inferences being made, such as flagging up a patient on the intensive care unit (ICU) as needing intervention more than a patient on the ward. The training data would show that the patient on the ICU to be at greater risk of death, but of course, the presence of the patient on ICU is a result of clinicians identifying that patient and bringing them to the ICU. Such logic may result in paradoxical inferences that ignore a deteriorating patient on a surgical ward.&lt;/p&gt;

&lt;p&gt;Do we have a framework that can certify such logic as being fit-for-purpose? Much like a pharmaceutical product, our more complex ML may have unintended consequences that are not easily demonstrable. In essence, the introduction of ML into a clinical environment becomes an intervention in a similar way to a pharmaceutical product. So, does that mean we must run randomised controlled trials of ML solutions?&lt;/p&gt;

&lt;h3 id=&quot;healthcare-technology-deployment&quot;&gt;Healthcare technology deployment&lt;/h3&gt;

&lt;p&gt;There are important differences between the deployment of technology within healthcare compared to the use of a pharmacological product. For example, a placebo may easily be substituted in place of an actual drug as a part of a randomised trial. If I start using a new treatment for hypertension, it is simply another prescription among many, rather than a change in working practice. However, if I deploy a new electronic patient record system, how can we determine it is effective and safe?&lt;/p&gt;

&lt;p&gt;Similarly, we have little data on the effect of machine learning on the behaviour and actions of clinical users. In particular, do we know what happens when users &lt;em&gt;assume&lt;/em&gt; technology will ensure that they are not making a mistake? Bob Wachter  2015 book, “The Digital Doctor”, explains in details the catalogue of errors that resulted in a patient being given a 39-fold overdose; in many of those errors, the fundamental issue was of inappropriate confidence and trust in the computer.&lt;/p&gt;

&lt;p&gt;However, we do not routinely run clinical trials when deploying new software systems within healthcare. When we introduce a systems for electronic prescribing, patients are not randomised into two groups. There is not a group of patients whose prescriptions are written electronically while another continues to have their medications prescribed on paper. Instead, a system might be deployed incrementally and rolled out piecemeal across an organisation, or the system is procured because there are safety data relating to the product or the type of product from a different organisation. If we know errors in prescription are common when using paper and they were reduced when an electronic system was deployed in another organisation, is this sufficient evidence of its performance?&lt;/p&gt;

&lt;p&gt;Would it be possible to run clinical trials of technology with the same rigour as those used for pharmaceutical products, not simply assessing performance against those claimed but looking for genuine efficacy? Certainly there would be considerable practical difficulties not least in trying to randomise patients to the intervention - in this case a new ML system - and placebo. Most organisations recognise that it is not possible to run randomised controlled trials of changes in their services, structure or indeed, information technology. Instead, they &lt;em&gt;should&lt;/em&gt; adopt a &lt;a href=&quot;/cis-design/2017/05/01/medical-record.html&quot;&gt;continuous improvement methodology&lt;/a&gt; in which they continuously measure, analyse and monitor their services and subsequently effect improvements and repeat.&lt;/p&gt;

&lt;h1 id=&quot;conclusions-for-ml&quot;&gt;Conclusions for ML&lt;/h1&gt;

&lt;p&gt;In conclusion, health professionals and patients are ‘information-poor’ and information technology must be used to improve access to information. However, there are risks in such an approach as important data may be lost within a large amount of irrelevant information and there will be an increasing need to curate, summarise and infer from these data in order to support clinical decision making.&lt;/p&gt;

&lt;p&gt;As such, my first suggestion is that we should be exploring the use of technology and ML to record and display the right information at the right time. It is possible for me to contrive what information I’d like to see when I see a patient with multiple sclerosis, but how can we do this at scale? Can we train deep learning systems with what information to show by giving those systems data on what information a clinician clicks on and reads and subsequently use those insights and heuristics to learn in real-time? Such a learning system should improve over time in response to the navigation choices made by clinicians in different contexts. As a result, instead of showing me a chronological list of investigations, I might be shown the most recent platelet count (dropped to 70 from a previous normal value) along with graph.&lt;/p&gt;

&lt;p&gt;Such a solution will be made much more powerful by ensuring that the ML systems have access to a wide-range of structured clinical information, such as diagnoses and procedures. My second suggestion is therefore to work on the development of a range of clinically useful tools to facilitate the routine, systematic and real-time collection of structured data.&lt;/p&gt;

&lt;p&gt;Thirdly, in order to look back at ML ‘decisions’, we must be able to see a snapshot of the data used by ML at the time of the decision. This means that it must be possible to either store or recreate what the algorithm saw at the time of making any inferences as well as a record of those inferences and the action taken.&lt;/p&gt;

&lt;p&gt;Fourthly, the introduction of ML within healthcare should aim to surpass the formal regulatory requirements. Any software deployment should adopt a continuous improvement methodology in which there is an attempt to measure its performance and safety in a real-life clinical environment. All ML systems should have training and subsequent validation using independent data via &lt;em&gt;in silico&lt;/em&gt; clinical trials and overseen by appropriate governance arrangements.&lt;/p&gt;

&lt;p&gt;In particular, any ML system that meets the requirements of a medical device requires additional safeguards and I would argue that current requirement to simply demonstrate its performance compared to what is claimed is insufficient.  Instead, I suggest that phase III clinical trials of medical devices containing artificial intelligence (AI) must be performed in a way that permits us as a health community to understand the value and the risk from the introduction of artificial intelligence over and above the other technology required.&lt;/p&gt;

&lt;p&gt;A controlled trial of ML might be possible within a single organisation but I would envisage a trial across multiple organisations would be needed in order to compare the efficacy and safety between those using AI and those who are not. For such a study, we would try to isolate the use of machine learning as the only difference between the control and intervention arm. As a result, deployment would need to be across both organisations with the only difference being the use of ML itself.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Mark&lt;/em&gt;&lt;/p&gt;</content><author><name></name></author><summary type="html">In a previous blog post, I have discussed the value of information technology in supporting clinical care, unashamedly stealing and modifying Google’s original mantra:</summary></entry><entry><title type="html">Clinical information system design: 3. Data standards and terminology</title><link href="https://www.wardle.org/cis-design/2017/05/02/data-standards.html" rel="alternate" type="text/html" title="Clinical information system design: 3. Data standards and terminology" /><published>2017-05-02T15:20:00+01:00</published><updated>2017-05-02T15:20:00+01:00</updated><id>https://www.wardle.org/cis-design/2017/05/02/data-standards</id><content type="html" xml:base="https://www.wardle.org/cis-design/2017/05/02/data-standards.html">&lt;p&gt;A terminology is a body of terms used within a particular subject of study or profession. A classification is a systematic organisation of things into classes. A classification system such as ICD-10 cannot be used as a terminology and many terminologies cannot be easily used as a classification system. This is an important distinction and relates to the how those data are primarily used.&lt;/p&gt;

&lt;h1 id=&quot;snomed-ct&quot;&gt;SNOMED CT&lt;/h1&gt;

&lt;p&gt;SNOMED CT is a very large and comprehensive terminology.  Importantly terms can be linked by multiple relationships to other terms. 
This makes it possible for software to determine that “multiple sclerosis” is a disease defined by “demyelination” of the “central nervous system”. 
When implemented properly, SNOMED CT enables software to make intelligent decisions about what to show, what data to request and what forms to present, based on the diagnoses entered. For example, the database would know that a patient had epilepsy if they were given a diagnosis of juvenile myoclonic epilepsy or frontal lobe epilepsy or any of the hundreds of other terms that are equivalent to a diagnosis of epilepsy.&lt;br /&gt;
Thus a command to ‘send an alert when a patient, belonging to a particular consultant, with motor neurone disease loses 5% of their body mass compared to their baseline at diagnosis’, can be implemented easily. SNOMED CT allows the underlying logic to simply ask whether the patient has a type of “motor neurone disease” and this would automatically include all patients with related diagnoses such as “primary lateral sclerosis” and “pseudobulbar palsy”.&lt;/p&gt;

&lt;p&gt;SNOMED CT is not confined to diagnostic and procedural information.  There are hierarchies covering a wide range of medical terminology including anatomical structures, pathology, occupations and ethnic origins. With local extensions such as the NHS’ DM&amp;amp;D (dictionary of medicines and devices) these codes can be used in any field that needs structured coded information.&lt;/p&gt;

&lt;p&gt;Another advantage is support for synonyms. A distinct clinical concept can and usually has multiple synonyms - for example “Granulomatosis with polyangiitis” was previously known as “Wegener granulomatosis”. With synonym support, a user entering an outdated or synonymous term would find the synonym and see it mapped into the new modern preferred description of the term.&lt;/p&gt;

&lt;p&gt;Within SNOMED CT, clinical terms are “concepts”, “synonyms” are “descriptions” and the relationships between concepts are recorded as “relationships”. While seemingly simple, as relationships themselves are defined by concepts (such as ‘IS-A’ as in “‘Motor neurone disease—IS-A—Disorder of nervous system”) it means that the relationship tree is infinitely extendable over time.&lt;/p&gt;

&lt;p&gt;SNOMED CT is owned by Snomed International - and is an international terminology, with the UK version managed by the UK Terminology Centre (UKTC) of the Health and Social Care Information Centre (HSCIC) - now called NHS Digital.  There are online &lt;a href=&quot;http://systems.hscic.gov.uk/data/uktc/training&quot;&gt;training resources&lt;/a&gt; as well as a simple online &lt;a href=&quot;http://browser.ihtsdotools.org&quot;&gt;SNOMED CT browser&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;I have developed an open-source terminology server that provides fast free-text search and navigation around the SNOMED CT hierarchy as well as providing semantic understanding for any concept, allowing client software to answer questions like “does this patient have a type of granulomatous disease?”, “was this patient born in Europe?” or even “is this drug a type of beta-blocker?” . It would answer yes to the first question simply by understanding the diseases that the patient has been listed as having, answering “yes” if a patient had sarcoidosis and “no” if they had multiple sclerosis. Similarly, it would respond with “yes” if a patient was recorded as being born in France but “no” if they were born in Afghanistan.  SNOMED CT provides the logical relationships in order to drive such computerised decision-making.&lt;/p&gt;

&lt;h1 id=&quot;information-models&quot;&gt;Information models&lt;/h1&gt;

&lt;p&gt;Each SNOMED CT concept, description and relationship has a unique and persistent identifier that can be stored in a data store. 
Most clinical applications persist information in a relational database and so a simple implementation may simply store the identifier as a foreign key to the row that represents that entity. However, whilst these terms have meaning when used in isolation (e.g. storing the identifier representing”myocardial infarction”), it is only when these terms are combined together in a logical way as part of a larger data model, that true meaning can be understood. It is analogous to definitions for individual words in a dictionary but true expression results only when these words are combined into sentences and paragraphs. As such, most concepts are only useful when considered within the information model in which it is recorded.&lt;/p&gt;

&lt;p&gt;The information model used in which SNOMED CT concepts are stored is therefore critical to derive understanding from what can be inferred from the recording of a concept. This is particularly important for a terminology such as SNOMED CT in which terms may be recorded together to form a compositional (post-coordinated) term such as “Family history of…” (281666001) and “Obesity” (414916001) or out of convenience represented as a single SNOMED CT term “Family history: Obesity” (160311006).&lt;/p&gt;

&lt;p&gt;If SNOMED CT had not only defined a terminology but also a wider information model then such compound pre-coordinated terms would be unnecessary and the recording of “obesity” within a model defining a family history would be sufficient. However, while compound pre-coordinated terms risk an explosion of terms to cater for multiple combinations, they do make it easier for end-users to find concepts that represent what they are trying to record and support workflows in which clinical terms are recorded in a relatively unstructured information model, such as that used in primary care historically using Read codes. Of course, SNOMED CT was developed as an amalgamation of SNOMED from the College of American Pathologists and Read (Clinical Terms Version 3) codes with the latter recorded prospectively and longitudinally in UK primary care systems in a relatively unstructured format. There are advantages in SNOMED CT being independent from the surrounding data model within which it is transmitted or stored particularly as SNOMED CT terms generally reflect core concepts relating to health, disease and the processes of care. As a result a range of models can be used with SNOMED CT and similarly, different terminologies can be bound to a model such as LOINC - LOINC is an alternative terminology focused on tests, measurements and observations — see &lt;a href=&quot;https://loinc.org&quot;&gt;LOINC&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;I generally recommend a highly structured approach to the storage of SNOMED CT codes in which the information model in which they are stored ensures no uncertainty in interpretation and that to simplify subsequent analysis and retrieval, compound pre-coordinated terms are decomposed into their components are stored appropriately. As such, users may enter information via a highly structured workflow in which the context is evident as part of the user interface such as recording family history or allergies or a less structured workflow in which terms can be entered and decomposed and entered into a more structured information model. Alternatively, an implementation may instead store the codes as entered and deal with ensuring that a diagnostic term recorded in a family history model is equivalent to the compound term.&lt;/p&gt;

&lt;p&gt;To provide evidence to support a highly structured approach, I suggest considering how one might use SNOMED CT to record examination findings. While there is a code for “supranuclear gaze palsy” (420675003) there is no compound code to record that there is an absence of this examination finding. While one could request an addition to SNOMED CT, it is much more appropriate to consider examination findings in two categories, those found and those not found. The recording of a lack of clinical sign is important in clinical practice as well as for medico-legal reasons. As such, the information model in which this clinical finding is recorded is critical in providing understanding. SNOMED CT does allow post-coordinated terms in which multiple terms are combined together to give meaning. One possible way of representing the ‘lack of’ a clinical finding is to post-coordinate with a negation concept to form a compositional term but I advocate using a robust information model as a simpler method of expressing clinical knowledge particularly when one considers &lt;em&gt;how&lt;/em&gt; users are expected to record such findings.&lt;/p&gt;

&lt;p&gt;Example information models which can record SNOMED CT terms in context are HL7 and openEHR. OpenEHR uses the term ‘archetype’ as a synonym for ‘information model’. The use of validated and published data structures support subsequent interoperability between disparate systems which can process that model. However, the use of a specific information model does not necessarily force the use of that model as a format in which to store data, but may be used only as a representation of data to be used for interoperability with other systems. Indeed, a focus on a model of any form improves the potential for interoperability because that model is likely to be an abstraction of real-life concepts and thus it becomes possible to map from one information model to another.&lt;/p&gt;

&lt;p&gt;However, even if two information models represent the same real-life concept and they look superficially similar, the process of mapping can introduce ambiguity and potentially even errors, particularly if a data element is present in one model but not in another. In addition, different terminologies may be used with an information model in a process called ‘terminology binding’ and so simply mandating a particular kind of information model does not guarantee interoperability.&lt;/p&gt;

&lt;h1 id=&quot;hl7&quot;&gt;HL7&lt;/h1&gt;
&lt;p&gt;Health Level Seven (HL7) is an international standards development organisation that publishes standards for healthcare interoperability. For more information, see the &lt;a href=&quot;http://www.hl7.org.uk&quot;&gt;HL7 website&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;HL7 publish a range of interoperability standards including HL7 V2, HL7 V3 and CDA, and the HL7 FHIR.&lt;/p&gt;

&lt;h2 id=&quot;hl7-v2&quot;&gt;HL7 V2&lt;/h2&gt;
&lt;p&gt;HL7 V2 refers to HL7’s currently most used health standard from HL7 first released in 1989 and deployed internationally. See more information &lt;a href=&quot;http://www.hl7.org/implement/standards/product_brief.cfm?product_id=185&quot;&gt;here&lt;/a&gt; and &lt;a href=&quot;http://www.hl7.org/about/FAQs/index.cfm?ref=nav&quot;&gt;here&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;It is fundamentally a messaging standard and early versions focused on ‘ADT’ messages, messaging relating to the admission, discharge and transfer of patients. Such messages are sent as ‘triggers’ and therefore adopt a ‘push’ model of health interoperability. HL7 has grown organically and iteratively over many years with an increasing number of message types including those to record clinical observations and laboratory results for example. The latest version is HL7 v2.6 which was approved as an ANSI standard in 2007.&lt;/p&gt;

&lt;h2 id=&quot;hl7-v3-and-the-rim&quot;&gt;HL7 V3 and the RIM&lt;/h2&gt;
&lt;p&gt;HL7 V3 was developed from 1992 to define a Reference Information Model (RIM) describing healthcare-related messages and trigger events relating to those messages. 
The RIM defines an object-orientated model in which types are sub-specialisms of a more generic type. For example, in the same way as bicycles and cars are &lt;em&gt;types&lt;/em&gt; of vehicles, a ‘Person’ is a type of a ‘Living Subject’ but veterinary patients such as dogs and cats are represented as a ‘Non-person living subject’. As in object-orientated programming languages, specialist models inherit attributes and behaviours from their more generic parent types.&lt;/p&gt;

&lt;p&gt;The three core classes in HL7 RIM are ‘Act’, ‘Entity’ and ‘Role’:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;An act is a record of something that has or will happen. This will usually include what has been done, to whom, by whom, when, where and how and possibly documenting why.&lt;/li&gt;
  &lt;li&gt;An entity is a living or non-living thing such as a person, animal or organisation.&lt;/li&gt;
  &lt;li&gt;A role represents a skill or competency of an Entity, such as patient, employee, place or organisation.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;The HL7 V3 standard is large and complex and many healthcare organisations with an existing infrastructure built using HL7 V2 have been reluctant to adopt the newer standard so HL7 RIM is not used as much as HL7 V2 internationally.&lt;/p&gt;

&lt;h2 id=&quot;hl7-v3-cda&quot;&gt;HL7 V3 CDA&lt;/h2&gt;
&lt;p&gt;The HL7 V3 Clinical Document Architecture (CDA) defines a document-based information model in which components of the HL7 V3 RIM is used as a header together with a document body consisting of a mixture of unstructured and structured data. As I discuss in my post on &lt;a href=&quot;/cis-design/2017/05/02/clinical-modelling.html&quot;&gt;clinical modelling&lt;/a&gt;, a document-based architecture is an appropriate abstraction of real-life processes and explicitly ensures that clinical information is recorded together with its context; such a document can stand in isolation and be understood by the reader. When contextual clues are removed, interpretation of structured and unstructured information is potentially hazardous. A document can be immutable once created and document lifecycle and process management including creation, editing and repudiation can be modelled in a straightforward manner.&lt;/p&gt;

&lt;p&gt;There are three CDA levels:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;CDA level one: has a header and human-readable body usually in an unstructured format such as free text or file types such as images or documents (e.g. Adobe PDF).&lt;/li&gt;
  &lt;li&gt;CDA level two: extends level one by including more structured data within the body of the document.&lt;/li&gt;
  &lt;li&gt;CDA level three: allows highly-structured data to be encoded at a high level of granularity.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;With the document paradigm limiting mismatch between model and real-life, adoption of the CDA standard has been widespread internationally. It is the most adopted &lt;a href=&quot;http://www.hl7.org/FHIR/comparison-cda.html&quot;&gt;HL7 V3 standard&lt;/a&gt;.
In addition, the different CDA levels permit flexibility in the recording of unstructured and structured data, easing adoption of the standard. Such an approach permits implementers to use level one of the HL7 CDA to store relatively unstructured documents initially but evolve over time to permit newer applications to store more structured information and yet remain interoperable.&lt;/p&gt;

&lt;h2 id=&quot;fhir&quot;&gt;FHIR&lt;/h2&gt;

&lt;p&gt;FHIR, &lt;a href=&quot;https://www.hl7.org/fhir/summary.html&quot;&gt;Fast Health Interoperability Resources&lt;/a&gt;, is a new framework created by HL7 which uses modern web services over HTTP to create, edit and share modular resources. Importantly, the HL7 FHIR standards are free to use without restriction and focus on data standards and the implementation of those standards within clinical systems.&lt;/p&gt;

&lt;p&gt;The use of FHIR does not mandate that existing and new clinical systems use FHIR standards to define their internal architecture or internal &lt;em&gt;storage&lt;/em&gt; formats, but the use of FHIR can provide an open and standard interface to permit interoperability between different systems created by different vendors. As such, an application or service can provide access to data in an open and extensible format by providing a FHIR server and consume different data as a FHIR client.&lt;/p&gt;

&lt;p&gt;There are a range of FHIR &lt;a href=&quot;http://www.hl7.org/FHIR/implementation.html&quot;&gt;frameworks&lt;/a&gt; including:&lt;/p&gt;
&lt;ul&gt;
  &lt;li&gt;Search: within a resource, such as searching for a patient.&lt;/li&gt;
  &lt;li&gt;Operations: on a resource such as fetching an encounter record or processing a message. These are in addition to the standard CREATE, READ, UPDATE and DELETE REST-based interactions.&lt;/li&gt;
  &lt;li&gt;Documents: representing a composition of other resources with a fixed presentation linked to context.&lt;/li&gt;
  &lt;li&gt;Messages: to allow messages to be sent in response to a specific event.&lt;/li&gt;
  &lt;li&gt;Services: to provide a representation of a service-orientated architecture within healthcare. See the &lt;a href=&quot;http://www.hl7.org/FHIR/services.html&quot;&gt;FHIR service documentation&lt;/a&gt; for more information.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;There is backwards-compatibility so that FHIR documents can contain HL7 V3 CDA documents. FHIR potentially improves the integration and interoperability between disparate systems. The standard uses open web standards over the HTTP protocol and so development can be straightforward. However, FHIR is still under active development at the time of writing and the current release is designated as a “draft standard for trial use”. As such, future versions of FHIR may result in non-compatible future changes.&lt;/p&gt;

&lt;h1 id=&quot;openehr&quot;&gt;openEHR&lt;/h1&gt;

&lt;p&gt;openEHR is an open standard for the recording of health-related data maintained by the &lt;a href=&quot;http://openehr.org&quot;&gt;OpenEHR foundation&lt;/a&gt;. It defines a multi-level information model in which the core model (the ‘reference model’) does &lt;em&gt;not&lt;/em&gt; include clinical information but focuses on core generic abstractions and process. Archetypes represent the clinical information model, with models created, edited and curated as part of a ‘clinical knowledge manager’ (CKM). This multi-level modelling approach means that health professionals can undertake clinical modelling independent of the underlying implementation. In addition, small and re-usable domain models can be aggregated into a ‘template’. For example, if a domain model contains ‘blood pressure’ and ‘heart rate’ then this model can be incorporated within a larger ‘template’ representing an emergency unit admission. An overview is available &lt;a href=&quot;http://www.openehr.org/releases/AM/latest/docs/Overview/Overview.html&quot;&gt;here&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;In addition, there is a new openEHR REST-based application programming interface (API) which proposes to define standards to which an openEHR implementation should adhere. However, the development of these standards is still in development and has not yet been finalised.&lt;/p&gt;

&lt;h1 id=&quot;loinc&quot;&gt;LOINC&lt;/h1&gt;
&lt;p&gt;LOINC is a freely available international standard for tests, measurements and observations. The official website is &lt;a href=&quot;https://loinc.org&quot;&gt;https://loinc.org&lt;/a&gt;.&lt;br /&gt;
Although limited in scope, it has been adopted by HL7 as the standard code system for laboratory results. In addition, there is a project to map LOINC codes to SNOMED-CT and vice versa.&lt;/p&gt;</content><author><name></name></author><summary type="html">A terminology is a body of terms used within a particular subject of study or profession. A classification is a systematic organisation of things into classes. A classification system such as ICD-10 cannot be used as a terminology and many terminologies cannot be easily used as a classification system. This is an important distinction and relates to the how those data are primarily used.</summary></entry><entry><title type="html">Clinical information system design: 2. Clinical modelling</title><link href="https://www.wardle.org/cis-design/2017/05/02/clinical-modelling.html" rel="alternate" type="text/html" title="Clinical information system design: 2. Clinical modelling" /><published>2017-05-02T12:06:00+01:00</published><updated>2017-05-02T12:06:00+01:00</updated><id>https://www.wardle.org/cis-design/2017/05/02/clinical-modelling</id><content type="html" xml:base="https://www.wardle.org/cis-design/2017/05/02/clinical-modelling.html">&lt;p&gt;A model is an abstraction of the real-world distilling knowledge into core concepts and processes. A model is a careful balance between complexity and over-simplification with models that are too complex providing brittle abstractions which are poorly generalisable and models that are too simple not supporting all of the demands placed upon it in real-life clinical scenarios.&lt;/p&gt;

&lt;p&gt;Modelling is an art but the approach can be made more systematic if modellers work iteratively within a supporting organisational environment with clinical and technical staff working together in  logical teams. Importantly, the scope of their model should be limited; large enough to solve the domain problems but small enough to result in a practical implementation. As such, it is important to have an appropriate separation of concerns in which teams can work independently of other teams as much as possible and that interfaces between that team and others are formalised on a contractual basis.&lt;/p&gt;

&lt;h1 id=&quot;high-level-functional-requirements&quot;&gt;High-level functional requirements&lt;/h1&gt;

&lt;p&gt;Clinical modelling is dependent on knowledge of the domain and the functional requirements to which the model will serve. It is useful to abstract these requirements to make them as generally-applicable as possible and not to generate needlessly specific requirements with limited applicability. However, the process of generated functional requirements and a subsequent data and process modelling is not a one-way process but must be an iterative two-way development in which there is feedback and discussion among all stakeholders and between all steps of requirements-gathering, modelling and implementation.&lt;/p&gt;

&lt;h1 id=&quot;the-process-of-developing-a-clinical-model&quot;&gt;The process of developing a clinical model&lt;/h1&gt;
&lt;p&gt;I suggest dividing clinical modelling into three related steps:&lt;/p&gt;

&lt;ol&gt;
  &lt;li&gt;Modelling data within a medical record&lt;/li&gt;
  &lt;li&gt;Modelling processes and workflow relating to a medical record&lt;/li&gt;
  &lt;li&gt;Implementation of a clinical model into a workable and practical solution.&lt;/li&gt;
&lt;/ol&gt;

&lt;p&gt;These three steps should be considered separately but are dependent on one another and inherently depend on the functional requirements. In designing clinical information systems, a data model may change infrequently or a design may even be correct in perpetuity; a systolic blood pressure recorded using a cuff on the right arm of an individual will always be a systolic blood pressure recorded using a cuff on the right arm of an individual. However, a model of the processes of care will likely change more frequently as a result of changes in working practices and service design, and an implementation may change even more frequently as a result of new technologies and devices.&lt;/p&gt;

&lt;p&gt;As each step is dependent on each other, modelling must be an iterative work with feedback loops between all steps rather than performed in sequence by different members of the team. An implementation cannot be designed without consideration of the data structures and processes that leverage the data within those structures and a model cannot be designed unless it is practical and efficient to perform an implementation. It also follows that clinical modelling must be performed by a team of individuals with a range of skills including those with important domain knowledge such as health professionals as well as those responsible for the design and implementation of the resulting software such as technical architects and software developers.&lt;/p&gt;

&lt;p&gt;Traditional waterfall-based design methods emphasise a sequential process involving business analysis and scoping, design, implementation, verification and then subsequent maintenance. Indeed, such methods are commonly used within NHS Wales with a focus on producing a product to solve a particular problem which then becomes “complete” and enters “maintenance”. I strongly believe that this approach is wrong and instead development should by underpinned by a robust model developed iteratively considering both workflow and implementation together with an understanding that any solutions will never be complete.&lt;/p&gt;

&lt;h2 id=&quot;modelling-the-medical-record&quot;&gt;Modelling the medical record&lt;/h2&gt;

&lt;p&gt;The breadth of knowledge within the medical record is potentially daunting with multiple types of data recorded in many different contexts and for many different purposes. Such data will need to be shown to users in order for them to make sense of a patient’s condition or clinical course, but also used to monitor a clinical service by providing real-time data on patient flow and progression along one of many clinical pathways.&lt;/p&gt;

&lt;p&gt;I advocate a clinical record in which much information is stored in a highly structured format. Some free-text is necessary but where possible, clinical information should be recorded using a standardised terminology such as SNOMED CT held within larger data structures representing the clinical model.&lt;/p&gt;

&lt;p&gt;Advances in technology such as new interventions, evolving diagnoses, new diagnostic tests and changing processes result in an ever-expanding knowledge base to which software systems must evolve and adapt. As such, no software system designed to model the medical record will ever be complete and as such, designing for incremental change in the medium and long-term is a pre-requisite. If real-world knowledge is ever-changing, then models too must constantly be refined and evolved. As such, the design and subsequent constant refinement and evolution of any model underpinning a complex clinical information system must be supported by an appropriate organisational structure which facilitates an iterative development approach. Such iterative development requires domain experts such as clinicians work closely in teams with developers to constantly refine their own understanding, focus the analysis of requirements and distil what they know to the core essentials that must underpin the design of any subsequent information system.&lt;/p&gt;

&lt;h3 id=&quot;electronic-medical-records-and-the-importance-of-context-and-provenance&quot;&gt;Electronic medical records and the importance of context and provenance.&lt;/h3&gt;
&lt;p&gt;An advantage of electronic records is that such records can be made universally available wherever they are needed such as when a patient presents to an emergency health facility or a new outpatient clinic or when the patient contacts a team via email or telephone. A disadvantage of electronic records is the need for real-time curation of patient records so that users are not overwhelmed by excessive information that is not relevant in their specific clinical context. It is therefore vital that any model supports not only the recording of information but the context and provenance in which those data were recorded and that views of aggregated information for a single patient take into account such contextual cues to ensure users see the information that is required and optionally filters information.&lt;/p&gt;

&lt;p&gt;Such issues also arise in paper records, particularly when a single patient has multiple volumes of notes. However, as paper records serve a single organisation end-users may find important information related to their own service  based on filing standards, paper colour, logos, page layout and the names of colleagues and can flick through the physical record more easily than a poorly curated and unstructured digital counterpart. However, paper records fail for patients looked after by multiple organisations, in which clinical correspondence from an outpatient clinic in one facility will usually not be available in another unless manual action by end-users is taken.&lt;/p&gt;

&lt;h2 id=&quot;modelling-the-processes-involving-medical-records&quot;&gt;Modelling the processes involving medical records.&lt;/h2&gt;

&lt;p&gt;Medical records are more than a simply narrative of what has happened to a patient listed in sequential order. A number of important processes and workflows exist that relate to the sending and receiving of paper-based forms that must be considered in any abstraction of medical enterprise. Paper records such as printed correspondence, request forms, results of investigations are sent to a responsible individual in order for them to be read and acted upon. On some occasions, such documentation is annotated, forming a narrative of the actions undertaken by the end-user or forwarded to another, forming a chain of correspondence. Electronic systems are potentially safer offering guarantees of sending and receiving such requests, providing full audit trail functionality and non-repudiation of comments and action. However, any process relating to a medical record must be modelled with as much care as the modelling of data structures.&lt;/p&gt;

&lt;p&gt;Most data standards relating to healthcare, such as HL7, openEHR, and FHIR, model the data relating to healthcare and not the processes and workflow that reflect the care of patients itself. While modelling data is an important pre-requisite in the conception and design of clinical information systems, modelling the processes and workflow that relate to that model is firstly an important test that data modelling is fit-for-purpose and secondly, critical itself in ensuring a resulting clinical information system will be a workable and valuable asset in providing healthcare services.&lt;/p&gt;

&lt;p&gt;Process and workflow will change frequently as clinical services evolve and develop and any model must take such changes into account so that any subsequent implementation can flexibly handle different workflows. Abstracting workflow is the most appropriate method to future-proof any clinical system and modellers must then consider how to model the configuration of more abstract workflows into a concrete implementation at runtime.&lt;/p&gt;

&lt;p&gt;In most clinical services, data and processes currently revolve around the completion and processing of clinical documents which are subsequently filed as part of a longitudinal prospective and immutable medical record. As such, a transactional document model is usually an appropriate reasonable and accurate abstraction of current processes of care.&lt;/p&gt;

&lt;h2 id=&quot;modelling-and-implementation&quot;&gt;Modelling and implementation&lt;/h2&gt;

&lt;p&gt;Tying a clinical model to its implementation is critical. A model cannot be designed without consideration of its implementation as it is possible to develop models of data and processes that would be impractical, cumbersome or inefficient to implement by developers. As such, close working between domain experts and software engineers is necessary to iteratively explore and improve a model to ensure it meets the demands of the domain and of practical software engineering considerations.&lt;/p&gt;

&lt;h3 id=&quot;avoiding-mismatches-between-a-model-and-real-life&quot;&gt;Avoiding mismatches between a model and real-life.&lt;/h3&gt;

&lt;p&gt;A mismatch between the model and real-life processes may cause confusion for users while models that are based on the fundamentals of a particular domain result in clinical systems that are intuitive to use with readily predictable functionality. A model should therefore abstract real-life processes and structures when possible so that end-users can easily understand what is happening within the software they are using and should not be surprised by unintended consequences. However, modelling real-life processes should not be an exact replica of an existing paper-based process but a careful abstraction designed to capture the essence of the process and to be more widely generalisable.&lt;/p&gt;

&lt;p&gt;While organisations, directorates, specialties, teams and even individual clinicians will have their own ways of working with disease and specialty specific data requirements, there is a danger in thinking that data modelling is simply getting a single group of domain experts in a room with a white-board. Instead, such work  is simply the start of a process in which these requirements are analysed and distilled and subsequently made as generic and widely applicable as possible and yet not made so generic that a subsequently developed model no longer meets the needs of the original functional requirements.&lt;/p&gt;</content><author><name></name></author><summary type="html">A model is an abstraction of the real-world distilling knowledge into core concepts and processes. A model is a careful balance between complexity and over-simplification with models that are too complex providing brittle abstractions which are poorly generalisable and models that are too simple not supporting all of the demands placed upon it in real-life clinical scenarios.</summary></entry><entry><title type="html">Clinical information system design: 1. The medical record</title><link href="https://www.wardle.org/cis-design/2017/05/01/medical-record.html" rel="alternate" type="text/html" title="Clinical information system design: 1. The medical record" /><published>2017-05-01T15:06:00+01:00</published><updated>2017-05-01T15:06:00+01:00</updated><id>https://www.wardle.org/cis-design/2017/05/01/medical-record</id><content type="html" xml:base="https://www.wardle.org/cis-design/2017/05/01/medical-record.html">&lt;blockquote&gt;
  &lt;p&gt;“You’re a victim of it or a triumph because of it. The human mind simply cannot carry all the information without error so the record becomes part of your practice.”&lt;/p&gt;

  &lt;p&gt;Dr Larry Weed, Internal Medicine Grand Rounds, 1971&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;The medical record encompasses and complex, disparate and evolving collection of information relating to the day-to-day care of an individual patient. Aggregated, such data provide valuable information about cohorts of patients managed by a clinical service supporting clinical governance and the management of the that service.&lt;/p&gt;

&lt;h1 id=&quot;paper-medical-records&quot;&gt;Paper medical records&lt;/h1&gt;

&lt;p&gt;Paper medical records are expensive, poorly accessible and do not support team working effectively. They are frequently poorly structured and while they contain large amounts of data, it is difficult to use those data to support clinical care. Paper records must be tracked and within a large organisation and such records need to be made available to clinical and administrative staff in order to appropriately manage the patient. This is particularly difficult when a single patient may be under the care of multiple services which is particularly common for patients with chronic long-term health conditions.&lt;/p&gt;

&lt;h1 id=&quot;clinical-governance&quot;&gt;Clinical governance&lt;/h1&gt;
&lt;blockquote&gt;
  &lt;p&gt;``If you can’t audit a thing for quality, it means you do not have the means to produce quality’’.&lt;/p&gt;

  &lt;p&gt;Dr Larry Weed, Internal Medicine Grand Rounds, 1971&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Clinical governance is a framework in which we are accountable for continuously improving the quality of our services safeguarding high standards of care by creating an environment in which excellence in clinical care can flourish.&lt;/p&gt;

&lt;p&gt;An important part of clinical governance is in the use of data to understand both process and outcomes. A typical clinical department will know how many patients are waiting for an outpatient appointment but will not be able to understand why they are waiting or understand a patient’s eventual outcome because usually only administrative data are collected systematically.&lt;/p&gt;

&lt;p&gt;Many clinical teams will undertake service improvement projects or clinical audits, in which a clinician identifies a problem, undertakes to measure that problem by clinical audit, analyses the results and makes an intervention in order to solve that problem. For example, a typical clinical audit might be in the assessment of risk of deep vein thrombosis in inpatients in which a doctor will systematically analyse the paper notes of a group of inpatients, record and present the results and enact a change to improve those results with a plan to re-audit after that intervention. Such a methodology has been formalised by the &lt;a href=&quot;https://www.isixsigma.com/dictionary/dmaic/&quot;&gt;Six Sigma quality initiative&lt;/a&gt; in which five steps form a virtuous cycle of continuous improvement:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/cis_design/dmaic.png&quot; alt=&quot;Dmaic&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Such continuous improvement is possible with paper records, but it cannot be performed systematically and routinely, requires a large amount of manual intervention and the cycle of improvement is slow; the analysis of results and a plan of action to effect improvement may take months with no guarantees that any systematic assessment of those interventions will be performed.&lt;/p&gt;

&lt;p&gt;It therefore follows that the routine and systematic collection of process and clinical outcome data offers the potential to radically improve the efficiency of the continuous improvement lifecycle as long as sufficient consideration is given to the use of such data, the context of those data and an understanding of the processes in which those data are involved.&lt;/p&gt;

&lt;h1 id=&quot;electronic-medical-records&quot;&gt;Electronic medical records&lt;/h1&gt;

&lt;p&gt;Electronic medical records and workflow should model and abstract real-life processes but digitisation of paper processes should not be a slavish exact copy of existing processes, particularly when technology offers opportunities to improve the process of healthcare.&lt;/p&gt;

&lt;p&gt;Indeed, we are facing an explosion of clinical data created by health professionals, administrators and patients themselves and clinical information systems must consider how they will integrate and make such data useful in clinical practice. For example, this figure:&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/cis_design/data_pipelines.png&quot; alt=&quot;Data Pipelines&quot; /&gt;&lt;/p&gt;

&lt;p&gt;shows how all of these sources of data are mutually dependent on one another. For example, what is the point in recording patient reported outcome measures if that data cannot be safely linked to a particular intervention or procedure and the co-morbidities and baseline assessments for that patient?&lt;/p&gt;

&lt;p&gt;The logical conclusion is that we will always have a multiplicity of systems and that in order to create robust clinical systems that outlive our current level of technological advancements, we have a responsibility to insist on open well-documented data standards, to integrate a well-developed clinical terminology, and foster collaboration, iterative development and embrace interoperability.&lt;/p&gt;</content><author><name></name></author><summary type="html">“You’re a victim of it or a triumph because of it. The human mind simply cannot carry all the information without error so the record becomes part of your practice.” Dr Larry Weed, Internal Medicine Grand Rounds, 1971</summary></entry><entry><title type="html">NHS hack days</title><link href="https://www.wardle.org/clinical-informatics/2017/05/01/nhs-hack-days.html" rel="alternate" type="text/html" title="NHS hack days" /><published>2017-05-01T08:57:36+01:00</published><updated>2017-05-01T08:57:36+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/05/01/nhs-hack-days</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/05/01/nhs-hack-days.html">&lt;p&gt;NHS hack days are weekends in which clinicians and software developers come together to try to develop information technology solutions for healthcare.&lt;/p&gt;

&lt;p&gt;There is a really good piece about them in the &lt;a href=&quot;http://www.bcs.org/content/conWebDoc/57646?utm_campaign=8245638_Health%20and%20care%20newsletter&amp;amp;utm_medium=email&amp;amp;utm_source=BCS%2C%20The%20Chartered%20Institute%20for%20IT&quot;&gt;BCS magazine by Dr Marcus Baw&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;I think they are a great idea and have attended two in Cardiff, most recently as one of the judges.&lt;/p&gt;

&lt;p&gt;However, I perceive the benefits to be principally about networking and fun, rather than successfully creating early working versions of products that are then rolled out into the NHS. How many great ideas have been rolled out?&lt;/p&gt;

&lt;p&gt;One of the problems is that projects essentially &lt;a href=&quot;http://nhshackday.com/resources/judging/&quot;&gt;start from nothing&lt;/a&gt;.&lt;/p&gt;

&lt;h4 id=&quot;an-open-platform&quot;&gt;An open platform&lt;/h4&gt;

&lt;p&gt;What would happen if, instead of starting with nothing, we provided teams with an open application programming interface (API) containing data, services and logic on which their solutions can run?&lt;/p&gt;

&lt;p&gt;This is the year in which this can truly become a reality, with standards such as FHIR and openEHR becoming adopted, we as a community need to start work on building “mocked services”.&lt;/p&gt;

&lt;p&gt;&lt;img src=&quot;/images/hackday/hackday-schematic.png&quot; alt=&quot;Hackday Schematic&quot; /&gt;&lt;/p&gt;

&lt;p&gt;Most of these services should be provided via FHIR endpoints and provide mock data. When it comes to running in a live environment, as long as there is a FHIR service that provides those same endpoints, an application will need less work in order to make it a production-ready application.&lt;/p&gt;

&lt;h4 id=&quot;what-needs-to-be-done&quot;&gt;What needs to be done?&lt;/h4&gt;

&lt;p&gt;The diagram above is deliberately simple. There are lots of complexities and lots of work to do, but it is achievable.&lt;/p&gt;

&lt;p&gt;The very nice feature of FHIR is that services can provide one or many different resources. One might write a single service that only provides patient demographic service. As such, one can implement functionality piecemeal and incrementally.&lt;/p&gt;

&lt;p&gt;I think we need to prioritise a list of resources and services in order:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Patient demographic service (PDS). We could start with fake data and then switch to using &lt;a href=&quot;https://github.com/nhs-ciao/ciao-pds-fhir&quot;&gt;https://github.com/nhs-ciao/ciao-pds-fhir&lt;/a&gt; for production - the Ciao PDS is a FHIR facade around the real NHS Spine PDS - or a local organisational patient administration system.&lt;/li&gt;
  &lt;li&gt;Terminology services, including SNOMED-CT. I have already built an open-source SNOMED-CT REST service, but it isn’t currently FHIR compatible. However, the last time I looked the FHIR terminology standard didn’t support free-text search. I’d like to add support for other terminologies, such as LOINC, and provide FHIR-compatible end-points.&lt;/li&gt;
  &lt;li&gt;Laboratory information management system. See &lt;a href=&quot;https://www.hl7.org/fhir/diagnosticreport.html&quot;&gt;FHIR diagnostic report resource&lt;/a&gt;&lt;/li&gt;
  &lt;li&gt;A UK NHS reference data service. This should be straightforward so that we take the &lt;a href=&quot;https://isd.digital.nhs.uk/trud3/user/guest/group/0/home&quot;&gt;NHS ODS data from TRUD&lt;/a&gt; and provide as FHIR end-points (e.g. see &lt;a href=&quot;https://www.hl7.org/fhir/organization.html&quot;&gt;organisations&lt;/a&gt;). In Wales, mapping practitioners is much easier as there is a central active directory, but I gather this might not be the case in England.&lt;/li&gt;
  &lt;li&gt;Document storage and retrieval. While the &lt;a href=&quot;https://www.hl7.org/fhir/documents.html&quot;&gt;FHIR standard&lt;/a&gt; explains how to aggregate resources into a document, initially I’d suggest focusing on a simple &lt;a href=&quot;https://www.hl7.org/fhir/documentreference.html&quot;&gt;document reference store&lt;/a&gt; to serve documents created by legacy systems.&lt;/li&gt;
  &lt;li&gt;Patient eFlow / e-observations service. See &lt;a href=&quot;https://www.hl7.org/fhir/observation.html&quot;&gt;observation FHIR resource&lt;/a&gt;.&lt;/li&gt;
&lt;/ul&gt;

&lt;p&gt;With these few core components and lots of fake data, NHS hack days could start adding value quickly making it much more likely that any solutions can evolve to become truly useful within the NHS.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Mark&lt;/em&gt;&lt;/p&gt;</content><author><name></name></author><summary type="html">NHS hack days are weekends in which clinicians and software developers come together to try to develop information technology solutions for healthcare.</summary></entry><entry><title type="html">An open source SNOMED-CT implementation</title><link href="https://www.wardle.org/clinical-informatics/2017/04/29/rsterminology-part2.html" rel="alternate" type="text/html" title="An open source SNOMED-CT implementation" /><published>2017-04-29T20:10:02+01:00</published><updated>2017-04-29T20:10:02+01:00</updated><id>https://www.wardle.org/clinical-informatics/2017/04/29/rsterminology-part2</id><content type="html" xml:base="https://www.wardle.org/clinical-informatics/2017/04/29/rsterminology-part2.html">&lt;p&gt;I have released an open-source SNOMED-CT terminology server called rsterminology. The source code is available from &lt;a href=&quot;https://github.com/wardle/rsterminology&quot;&gt;https://github.com/wardle/rsterminology&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;It is software that is designed to be used by other software, rather than by end-users. I have shown videos of how I use this in an electronic patient record system in &lt;a href=&quot;/clinical-informatics/2017/04/28/importance-of-cohorts.html&quot;&gt;previous posts&lt;/a&gt;. It runs as a java microservice and is currently deployed within NHS Wales.&lt;/p&gt;

&lt;p&gt;I have installed a working version of this software on a very small virtual machine for demonstration purposes. It is not intended for production use please! I will monitor usage and add throttling or shut down the service if this is misused.&lt;/p&gt;

&lt;blockquote&gt;
  &lt;p&gt;For clinical users, I have just created (29th April) a quick SNOMED-CT search facility on a web page so that you can enter terms like “MS” or “DM” or “IHD” or “amlodipine” and see how autocomplete can work. The application is available &lt;a href=&quot;https://msdata.org.uk/apps/WebObjects/SnomedBrowser.woa/&quot;&gt;here&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;

&lt;p&gt;Here are some simple examples of how it can be used:&lt;/p&gt;

&lt;ul&gt;
  &lt;li&gt;Fetch information about a single concept with a known identifier:
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/concepts/24700007&quot;&gt;http://msdata.org.uk:8080/snomedct/concepts/24700007&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://apigee.com/console/others?req=%7B%22resource%22%3A%22msdata.org.uk%3A8080%2Fsnomedct%2Fconcepts%2F24700007%22%2C%22params%22%3A%7B%22query%22%3A%7B%7D%2C%22template%22%3A%7B%7D%2C%22headers%22%3A%7B%7D%2C%22body%22%3A%7B%22attachmentFormat%22%3A%22mime%22%2C%22attachmentContentDisposition%22%3A%22form-data%22%7D%7D%2C%22verb%22%3A%22get%22%7D&quot;&gt;via Apigee console&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;This shows information about multiple sclerosis&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Get the synonyms for a given concept
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/concepts/24700007/descriptions&quot;&gt;http://msdata.org.uk:8080/snomedct/concepts/24700007/descriptions&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://apigee.com/console/others?req=%7B%22resource%22%3A%22msdata.org.uk%3A8080%2Fsnomedct%2Fconcepts%2F24700007%2Fdescriptions%22%2C%22params%22%3A%7B%22query%22%3A%7B%7D%2C%22template%22%3A%7B%7D%2C%22headers%22%3A%7B%7D%2C%22body%22%3A%7B%22attachmentFormat%22%3A%22mime%22%2C%22attachmentContentDisposition%22%3A%22form-data%22%7D%7D%2C%22verb%22%3A%22get%22%7D&quot;&gt;via Apigee console&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Understand what a concept means, semantically, by virtue of subsumption (the IS-A relationships)
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/concepts/24700007/recursiveParents&quot;&gt;http://msdata.org.uk:8080/snomedct/concepts/24700007/recursiveParents&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://apigee.com/console/others?req=%7B%22resource%22%3A%22msdata.org.uk%3A8080%2Fsnomedct%2Fconcepts%2F24700007%2FrecursiveParents%22%2C%22params%22%3A%7B%22query%22%3A%7B%7D%2C%22template%22%3A%7B%7D%2C%22headers%22%3A%7B%7D%2C%22body%22%3A%7B%22attachmentFormat%22%3A%22mime%22%2C%22attachmentContentDisposition%22%3A%22form-data%22%7D%7D%2C%22verb%22%3A%22get%22%7D&quot;&gt;via Apigee console&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;In this example you see that multiple sclerosis is a disease of the nervous system for example.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Perhaps the most powerful feature is free-text searching. You would not usually search the whole of SNOMED-CT but instead limit to particular sub-trees such as diagnoses, procedures, ethnic origins etc.
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/search?s=msa&amp;amp;root=64572001&quot;&gt;http://msdata.org.uk:8080/snomedct/search?s=msa&amp;amp;root=64572001&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://apigee.com/console/others?req=%7B%22resource%22%3A%22msdata.org.uk%3A8080%2Fsnomedct%2Fsearch%3Fs%3Dmsa%26root%3D64572001%22%2C%22params%22%3A%7B%22query%22%3A%7B%22parameters_name_0%22%3A%22s%22%2C%22parameters_value_0%22%3A%22msa%22%2C%22parameters_name_1%22%3A%22root%22%2C%22parameters_value_1%22%3A%2264572001%22%7D%2C%22template%22%3A%7B%7D%2C%22headers%22%3A%7B%22headers_name_0%22%3A%22s%22%2C%22headers_value_0%22%3A%22mult%20scler%22%7D%2C%22body%22%3A%7B%22attachmentFormat%22%3A%22mime%22%2C%22attachmentContentDisposition%22%3A%22form-data%22%7D%7D%2C%22verb%22%3A%22get%22%7D&quot;&gt;via Apigee console&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;Here we search for “MSA” but only in the “diagnoses” hierarchy - which has the concept identifier &lt;a href=&quot;http://msdata.org.uk:8080/snomedct/concepts/64572001&quot;&gt;64572001&lt;/a&gt;.&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Let’s now let our users choose a country of birth. The root representing these concepts is &lt;a href=&quot;http://msdata.org.uk:8080/snomedct/concepts/370159000&quot;&gt;370159000&lt;/a&gt;.
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/search?root=370159000&amp;amp;s=eng&quot;&gt;http://msdata.org.uk:8080/snomedct/search?root=370159000&amp;amp;s=eng&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://apigee.com/console/others?req=%7B%22resource%22%3A%22http%3A%2F%2Fmsdata.org.uk%3A8080%2Fsnomedct%2Fsearch%3Froot%3D370159000%26s%3Deng%22%2C%22params%22%3A%7B%22query%22%3A%7B%22parameters_name_0%22%3A%22root%22%2C%22parameters_value_0%22%3A%22370159000%22%2C%22parameters_name_1%22%3A%22s%22%2C%22parameters_value_1%22%3A%22eng%22%7D%2C%22template%22%3A%7B%7D%2C%22headers%22%3A%7B%22headers_name_0%22%3A%22s%22%2C%22headers_value_0%22%3A%22mult%20scler%22%7D%2C%22body%22%3A%7B%22attachmentFormat%22%3A%22mime%22%2C%22attachmentContentDisposition%22%3A%22form-data%22%7D%7D%2C%22verb%22%3A%22get%22%7D&quot;&gt;via Apigee console&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
  &lt;li&gt;Finally, let’s parse a medication such as amlodipine 5mg od, which means amlodipine should be taken 5mg per day once daily:
    &lt;ul&gt;
      &lt;li&gt;&lt;a href=&quot;http://msdata.org.uk:8080/snomedct/dmd/parse?s=amlodipine 5mg od&quot;&gt;http://msdata.org.uk:8080/snomedct/dmd/parse?s=amlodipine 5mg od&lt;/a&gt;&lt;/li&gt;
      &lt;li&gt;&lt;a href=&quot;https://apigee.com/console/others?req=%7B%22resource%22%3A%22msdata.org.uk%3A8080%2Fsnomedct%2Fdmd%2Fparse%3Fs%3Damlodipine%205mg%20od%22%2C%22params%22%3A%7B%22query%22%3A%7B%22parameters_name_0%22%3A%22s%22%2C%22parameters_value_0%22%3A%22amlodipine%205mg%20od%22%7D%2C%22template%22%3A%7B%7D%2C%22headers%22%3A%7B%22headers_name_0%22%3A%22s%22%2C%22headers_value_0%22%3A%22mult%20scler%22%7D%2C%22body%22%3A%7B%22attachmentFormat%22%3A%22mime%22%2C%22attachmentContentDisposition%22%3A%22form-data%22%7D%7D%2C%22verb%22%3A%22get%22%7D&quot;&gt;via Apigee console&lt;/a&gt;&lt;/li&gt;
    &lt;/ul&gt;
  &lt;/li&gt;
&lt;/ul&gt;</content><author><name></name></author><summary type="html">I have released an open-source SNOMED-CT terminology server called rsterminology. The source code is available from https://github.com/wardle/rsterminology.</summary></entry></feed>